ProCap Acquisition Corp (PCAP) — 10-K

Filed 2026-03-17 · Period ending 2025-12-31 · 48,008 words · SEC EDGAR

← PCAP Profile · PCAP JSON API

# ProCap Acquisition Corp (PCAP) — 10-K

**Filed:** 2026-03-17
**Period ending:** 2025-12-31
**Accession:** 0001213900-26-028492
**Source:** [SEC EDGAR](https://www.sec.gov/Archives/edgar/data/2056634/000121390026028492/)
**Origin leaf:** 8007b3ffe2b951e928eb35fd3059daeddee99dbeb39381b178a38cb9d6a707fc
**Words:** 48,008



---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K 
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
For the fiscal year ended December 31, 2025 
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
For the transition period from to
Commission file number: 001-42659 
ProCap Acquisition Corp 
(Exact name of registrant as specified in its
charter)
| Cayman Islands | | N/A | |
| 
(State or other jurisdiction of incorporation or organization) | 
| 
(I.R.S. Employer Identification No.) | |
| 600 Lexington Ave, Floor 2 New York, New York | | 10022 | |
| 
(Address of principal executive offices) | 
| 
(Zip Code) | |
Registrants telephone number, including area code: (305) 938-0912 
Securities registered pursuant to Section 12(b) of the Act:
| 
Title of each class | 
| 
Trading Symbol(s) | 
| 
Name of each exchange on which registered | |
| Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant | | PCAPU | | The Nasdaq Stock Market LLC | |
| 
| 
| 
| 
| 
| |
| Class A ordinary shares, par value $0.0001 per share | | PCAP | | The Nasdaq Stock Market LLC | |
| 
| 
| 
| 
| 
| |
| Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | | PCAPW | | The Nasdaq Stock Market LLC | |
Securities registered pursuant to Section 12(g)
of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No 
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging
growth company in Rule 12b-2 of the Exchange Act.
| 
Large accelerated filer | 
| 
| 
Accelerated filer | 
| |
| Non-accelerated filer | | | Smaller reporting company | | |
| Emerging growth company | | | | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 
Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrants
executive officers during the relevant recovery period pursuant to 240.10D-1(b). 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No 
As of June 30, 2025, the last business day of the registrants most recently completed second fiscal quarter, the aggregate market value of the registrants ordinary shares held by non-affiliates of the registrant was approximately $268,000,000, based on the closing price of the registrants Class A ordinary shares on the Nasdaq Stock Market LLC on June 30, 2025 of $10.72 per share. 
As of March 12, 2026 there were 25,430,000 Class A ordinary shares, par value $0.0001 per share, and 6,250,000 Class B ordinary shares, par value $0.0001 per share, of the registrant issued and outstanding, including 25,000,000 Class A ordinary shares subject to possible redemption. 
TABLE OF CONTENTS
| 
| 
PAGE | |
| 
PART I | 
| 
| |
| 
Item 1. | 
Business. | 
1 | |
| 
Item 1A. | 
Risk Factors. | 
20 | |
| 
Item 1B. | 
Unresolved Staff Comments. | 
25 | |
| 
Item 1C. | 
Cybersecurity. | 
25 | |
| 
Item 2. | 
Properties. | 
25 | |
| 
Item 3. | 
Legal Proceedings. | 
25 | |
| 
Item 4. | 
Mine Safety Disclosures. | 
25 | |
| 
| 
| 
| |
| 
PART II | 
| |
| 
Item 5. | 
Market for Registrants Common Equity, Related
Stockholder Matters and Issuer Purchases of Equity Securities. | 
26 | |
| 
Item 6. | 
[Reserved] | 
27 | |
| 
Item 7. | 
Managements Discussion and Analysis of Financial Condition and
Results of Operations. | 
27 | |
| 
Item 7A. | 
Quantitative and Qualitative Disclosures About Market Risk. | 
29 | |
| 
Item 8. | 
Financial Statements and Supplementary Data. | 
30 | |
| 
Item 9. | 
Changes in and Disagreements with Accountants on Accounting and Financial
Disclosure. | 
30 | |
| 
Item 9A. | 
Controls and Procedures. | 
30 | |
| 
Item 9B. | 
Other Information. | 
30 | |
| 
Item 9C. | 
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. | 
30 | |
| 
| 
| 
| |
| 
PART III | 
| |
| 
Item 10. | 
Directors, Executive Officers and Corporate Governance. | 
31 | |
| 
Item 11. | 
Executive Compensation. | 
37 | |
| 
Item 12. | 
Security Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters. | 
38 | |
| 
Item 13. | 
Certain Relationships and Related Transactions, and Director Independence. | 
40 | |
| 
Item 14. | 
Principal Accountant Fees and Services. | 
42 | |
| 
| 
| 
| |
| 
PART IV | 
| |
| 
Item 15. | 
Exhibit and Financial Statement Schedules. | 
43 | |
| 
Item 16. | 
Form 10-K Summary. | 
43 | |
| 
| 
| 
| |
| 
SIGNATURES | 
45 | |
i
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Report (as defined below), including, without
limitation, statements under Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations,
includes forward-looking statements within the meaning of Section 27A of the Securities Act (as defined below) and Section 21E of the
Exchange Act (as defined below). Some of the statements contained in this Report may constitute forward-looking statements
for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our
or our Management Teams expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements
that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions,
are forward-looking statements. The words anticipate, believe, continue, could,
estimate, expect, intend, may, might, plan, possible,
potential, predict, project, should, would and similar expressions
may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking
statements in this Report may include, for example, statements about:
| 
| our ability to select an appropriate target business or businesses; | 
|
| 
| our ability to complete our initial Business Combination; | 
|
| 
| our expectations around the performance of the prospective
target business or businesses; | 
|
| 
| our success in retaining or recruiting, or changes required
in, our officers, key employees or directors following our initial Business Combination; | 
|
| 
| our officers and directors allocating their time to other
businesses and potentially having conflicts of interest with our business or in approving our initial Business Combination; | 
|
| 
| our potential ability to obtain additional financing to complete
our initial Business Combination; | 
|
| 
| the potential incentive to consummate an initial Business
Combination with an acquisition target that subsequently declines in value or is unprofitable for public investors due to the low initial
price for the Founders Shares (as defined below) paid by our Sponsor (as defined below); | 
|
| 
| the ability of our Management Team (as defined below) to
generate and execute on potential acquisition opportunities that will generate value for our shareholders; | 
|
| 
| our pool of prospective target businesses; | 
|
| 
| the adverse impacts of certain events (such as terrorist
attacks, natural disasters or a significant outbreak of infectious diseases) on our ability to consummate an initial Business Combination; | 
|
| 
| our public securities potential liquidity and trading; | 
|
| 
| the value of the founder Shares following completion of our
initial Business Combination likely being substantially higher than the nominal price paid for them, even if the trading price of our
Public Shares (as defined below) at such time is substantially less than the Redemption Price (as defined below); | 
|
| 
| the use of proceeds not held in the Trust Account or available
to us from interest income on the Trust Account balance; | 
|
| 
| the Trust Account not being subject to claims of third parties; | 
|
| 
| the impact on the amount held in the Trust Account, our capitalization,
principal shareholders and other impacts on our Company (as defined below) or Management Team should we seek to extend the Combination
Period (as defined below) consistent with applicable laws, regulations and stock exchange rules; | 
|
ii
| 
| our financial performance; or | 
|
| 
| the other risks and uncertainties discussed in Item
1A. Risk Factors below. | 
|
Additionally, in 2024, the SEC (as defined below)
adopted additional rules and regulations relating to SPACs (as defined below). The 2024 SPAC Rules (as defined below) require, among other
matters, (i) additional disclosures relating to SPAC sponsors and related persons; (ii) additional disclosures relating to SPAC Business
Combination transactions (iii) additional disclosures relating to dilution and to conflicts of interest involving sponsors and their
affiliates in connection with proposed Business Combination transactions; (iv) additional disclosures regarding projections included in
SEC filings in connection with proposed Business Combination transactions and (v) the requirement that both the SPAC and its target
company be co-registrants in connection with registration statements relating to proposed Business Combination transactions. In addition,
the SECs adopting release provided guidance describing circumstances in which a SPAC could become subject to regulation under the
Investment Company Act (as defined below), including its duration, asset composition, business purpose, and the activities of the SPAC
and its Management Team. The 2024 SPAC Rules may materially affect our ability to negotiate and complete our initial Business Combination
and may increase the costs and time related thereto.
The forward-looking statements contained in this
Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be
no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a
number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance
to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include,
but are not limited to, those factors described under the heading *Risk Factors.* Should one or more of these risks
or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those
projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
In addition, statements that contain we
believe and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information
available to us as of the date of this Report. Although we believe that this information provides a reasonable basis for these statements,
this information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry
into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely
on these statements.
Unless otherwise stated in this Report, or the
context otherwise requires, references to:
| 
| 2024 SPAC Rules are to the rules and regulations
for SPACs adopted by the SEC on January 24, 2024, which became effective on July 1, 2024; | 
|
| 
| Administrative Services Agreement are to the
Administrative Services Agreement, dated May 20, 2025, which we entered into with an affiliate of our Sponsor, for office space, utilities
and secretarial and administrative support; | 
|
| 
| Amended and Restated Charter are to our Amended
and Restated Memorandum and Articles of Association, as amended and restated, and currently in effect; | 
|
| 
| Board of Directors or Board are
to our board of directors; | 
|
| 
| BTIG are to BTIG, LLC, the sole book-running
manager for and representative of the several Underwriters of the Initial Public Offering; | 
|
| 
| Business Combination are to a merger, capital
share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses; | 
|
| 
| ClassA ordinary shares are to our ClassA
ordinary shares of par value $0.0001 per share in the share capital of the Company; | 
|
iii
| 
| ClassB ordinary shares are to our ClassB
ordinary shares of par value $0.0001 per share in the share capital of the Company; | 
|
| 
| Combination Period are to (i)the period
ending on the date that is 24months from the closing of the Initial Public Offering, or such earlier liquidation date as our Board
of Directors may approve, in which we must complete an initial Business Combination or (ii)such other time period in which we must
complete an initial Business Combination pursuant to an amendment to our Amended and Restated Charter. Our shareholders can also vote
at any time to amend our Amended and Restated Charter to modify the amount of time we will have to complete an initial Business Combination,
in which case our Public Shareholders will be offered an opportunity to redeem their Public Shares; | 
|
| 
| Companies Act are to the Companies Act (As
Revised) of the Cayman Islands as the same may be amended from time to time; | 
|
| 
| Exchange Act are to the Securities Exchange
Act of 1934, as amended; | 
|
| 
| Excise Tax are to the U.S. federal 1% excise
tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly
traded foreign corporations occurring on or after January 1, 2023 as provided for by the Inflation Reduction Act of 2022; | 
|
| 
| Founder Shares are to ClassB ordinary
shares initially purchased by our Sponsor in a private placement prior to the Initial Public Offering and the ClassA ordinary shares
that will be issued upon the automatic conversion of the ClassB ordinary shares concurrently with or immediately following the
consummation of our initial Business Combination or earlier at the option of the holders thereof as described herein (for the avoidance
of doubt, such ClassA ordinary shares will not be Public Shares); | 
|
| 
| Initial Public Offering or IPO
are to the Initial Public Offering that we consummated on May 22, 2025; | 
|
| 
| IPO Registration Statement are to the Registration
Statement on Form S-1 initially filed with the SEC on April 30, 2025, as amended, and declared effective on May 20, 2025 (File No. 333-286876); | 
|
| 
| Initial Shareholders are to our Sponsor and
any other holders of our Founder Shares immediately prior to the Initial Public Offering; | 
|
| 
| Investment Company Act are to the Investment
Company Actof1940, as amended; | 
|
| 
| Letter Agreement are to the Letter Agreement,
dated May 20, 2025, which we entered into with our Sponsor and our directors and officers; | 
|
| 
| Management or our Management Team
are to our officers and directors; | 
|
| 
| Ordinary Resolution are to a resolution of
the company passed by a simple majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where
proxies are allowed, by proxy at a general meeting of the company, or a resolution approved in writing by all of the holders of the issued
shares entitled to vote on such matter (or such lower threshold as may be allowed under the Companies Act from time to time); | 
|
| 
| Ordinary Shares are to our ClassA ordinary
shares and our ClassB ordinary shares; | 
|
| 
| Private Placement Units are to the Private
Placement Units issued to our Sponsor in a private placement simultaneously with the closing of the Initial Public Offering; | 
|
| 
| Private Placement Units Purchase Agreement
are to the Private Placement Units purchase agreement, dated May 20, 2025, which we entered into with our Sponsor; | 
|
| 
| Public Shares are to ClassA ordinary
shares sold as part of the Units sold in our Initial Public Offering, , and does not include any Founder Shares; | 
|
iv
| 
| Public Shareholders are to the holders of our
Public Shares, including our Initial Shareholders and our Management Team to the extent our Initial Shareholders or members of our Management
Team purchase Public Shares, provided that each initial shareholders or member of our Management Teams status as a Public
Shareholder will only exist with respect to such Public Shares; | 
|
| 
| Registrar of Companies are to the Registrar
of Companies of the Cayman Islands; | 
|
| 
| Report is to this Annual Report on Form 10-K
for the fiscal year ended December 31, 2025; | 
|
| 
| SEC are to the U.S. Securities and Exchange
Commission; | 
|
| 
| Securities Act is to the Securities Act of
1933, as amended; | 
|
| 
| Special Resolution are to a resolution of the
Company passed by a majority of at least two-thirds (2/3) (or such higher approval threshold as specified in the Companys Amended
and Restated Charter) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed,
by proxy at a general meeting of the company of which notice specifying the intention to propose the resolution as a Special Resolution
has been duly given, or a resolution approved in writing by all of the holders of the issued shares entitled to vote on such matter (or
such lower threshold as may be allowed under the Companies Act from time to time); | 
|
| 
| SPACs are to special purpose acquisition companies; | 
|
| 
| Sponsor are to ProCap Acquisition Sponsor,
LLC, a Delaware limited liability company; | 
|
| 
| Trust Account are to the U.S.-based Trust Account
in which an amount of $250,000,000 from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement
Units in the Private Placement was placed following the closing of the Initial Public Offering; | 
|
| 
| Underwriter or Underwriters refers
to BTIG, the underwriter of the Initial Public Offering; | 
|
| 
| Underwriting Agreement are to the Underwriting
Agreement, dated May 20, 2025, by and between the Company and BTIG, LLC, as representative of the several underwriters of the Initial
Public Offering; | 
|
| 
| Unit are to the units sold in our Initial Public
Offering, which consist of one ClassA ordinary share and one-third of one redeemable warrant; | 
|
| 
| Warrants or Public Warrants are
to the warrants sold in our Initial Public Offering and thereafter in the open market; | 
|
| 
| we, us, Company
or our Company are to ProCap Acquisition Corp, a Cayman Islands exempted company. | 
|
v
PART I
Item 1. Business.
Overview 
We are a blank check company incorporated on January
2, 2025 as a Cayman Islands exempted company and formed for the purpose of effecting a Business Combination with one or more businesses
or entities. To date, we have not selected any Business Combination target and our efforts have been limited to (i) organizational activities,
(ii) activities related to our Initial Public Offering, and (iii) searching for a Business Combination target. We have also generated
no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial Business Combination.
We may pursue an initial Business Combination
target in any business or industry or at any stage of its corporate evolution. Our primary focus, however, is in completing a Business
Combination with a target in the financial services sector. Our Management Team has an extensive track record of acquiring attractive
assets at disciplined valuations, investing in growth while fostering financial discipline and improving business results. Although our
Management assess the risks inherent in a particular target business with which we may combine, we cannot assure our shareholders that
this assessment will result in our identifying all risks that a target business may encounter. Furthermore, some of those risks may be
outside of our control, meaning that we can do nothing to control or reduce the chances that those risks will adversely affect a target
business.
We believe that the experience and capabilities
of our Management Team makes us an attractive partner to potential target businesses, will enhance our ability to complete a successful
Business Combination, and will bring value to the business post-Business Combination. Our Management Team has broad sector knowledge though
their collective involvement across a variety of industries, as well as extensive global capital markets experience, with local and cross-border
capabilities allowing access to different sectors of the capital markets.
The 2024 SPAC Rules may materially affect our
ability to negotiate and complete our initial Business Combination and may increase the costs and time related thereto.
Initial Public Offering
On May 22, 2025, we consummated our Initial Public
Offering of 25,000,000 units including the partial exercise by the Underwriters of their over-allotment option in the amount of 3,000,000
Units, at $10.00 per Unit, generating gross proceeds to us of $250,000,000. Each Unit consists of one Class A ordinary share and one-third
of one public warrant.
Simultaneously with the closing of the Initial
Public Offering, we consummated the sale of 430,000 units (the Private Placement Units) at a price of $10.00 per Private
Placement Unit, in a private placement to our Sponsor, generating gross proceeds of $4,300,000 (the Private Placement).
Each Private Placement Unit consists of one Class A ordinary share and one-third of one redeemable warrant (the Private Placement
Warrants and together with the Public Warrants, the Warrants). Each whole Warrant entitles the holder to purchase
one Class A ordinary share at a price of $11.50 per share, subject to adjustment.
A total of $250,000,000, comprised of the proceeds
from the Initial Public Offering and the Private Placement, was placed in the Trust Account (the Trust Account) maintained
by Odyssey Transfer and Trust Company, acting as trustee.
It is the job of our Sponsor and Management Team
to complete our initial Business Combination. Our Management Team is led by Anthony Pompliano, our Chief Executive Officer, and Catalina
Abbey, our Chief Financial Officer. In addition, our Management Team is aided by Brent Saunders (our Special Advisor). We
must complete our initial Business Combination by May 22, 2027, which is 24 months from the closing of our Initial Public Offering, unless
we decide to pursue an amendment to our Amended and Restated Charter in order to extend the Combination Period. If our initial Business
Combination is not consummated by the end of our Combination Period (as extended, if it has been extended), then, unless our Board of
Directors shall otherwise determine, our existence will terminate, and we will distribute all amounts in the Trust Account, as described
further herein.
1
We may seek to extend the Combination Period,
consistent with applicable laws, regulations and stock exchange rules, by amending our Amended and Restated Charter. Such an amendment
would require the approval of our Public Shareholders, who will be provided the opportunity to redeem all or a portion of their Public
Shares in connection with the vote on such approval. Such redemptions will decrease the amount held in our Trust Account and our capitalization,
and may affect our ability to maintain our listing on Nasdaq. In addition, the Nasdaq Rules currently require SPACs (such as us) to complete
our initial Business Combination in accordance with the Nasdaq 36-Month Requirement. If we do not meet the Nasdaq 36-Month Requirement,
our securities will likely be subject to a suspension of trading and delisting from Nasdaq. Our Sponsor may also, in its discretion, explore
transactions under which it would sell its interest in our Company to another sponsor entity, which may result in a change to our Management
Team.
Prior SPAC Experience
Below is the SPAC Business Combination in which
our Special Advisor has participated, along with certain other information:
**
*SPAC (Vesper Healthcare Acquisition Corp),
Target (The Beauty Health Company).*SPAC consummated its IPO on October2, 2020 of 46,000,000units, with
each unit consisting of one ClassA ordinary share and one-third of one redeemable warrant to purchase one ClassA ordinary
share exercisable at $11.50 per share, generating gross proceeds of $460.0million. No extension of SPAC term. Approximately 5.8%
redemptions in connection with the business combination. The Beauty Health Company trades on the Nasdaq Capital Market under the symbol
SKIN, and the price of the common stock has ranged from $1.12 to $29.49 following consummation of the business combination,
with a closing price of $1.77 on January8, 2025.
However, in recentyears, a number of target
businesses have underperformed financially post-business combination with a SPAC.As a result, we cannot assure our shareholders
that we will properly ascertain or assess all of the significant risk factors associated with a target business or that the price of the
shares of the combined entity post-business combination will increase.
Sponsor Information
Our Sponsor is a Delaware limited liability company,
which was formed in December 2024 to invest in our Company. Although our Sponsor is permitted to undertake any activities permitted under
the Delaware Limited Liability Company Act and other applicable law, our Sponsors business is focused on investing in our Company.
The sole managing member of the Sponsor is Inflection Points, Inc. d/b/a Professional Capital Management. Mr.Pompliano serves as
our Chief Executive Officer and director. Mr.Pompliano controls the management of our Sponsor, including the exercise of voting
and investment discretion over the securities of our Company held by our Sponsor.Other than members of our Management Team who are
members of our Sponsor, none of the other members of our Sponsor will participate in our Companys activities.
Because our Sponsor acquired the Founder Shares
at a nominal price ($0.004 per share), our Public Shareholders incurred immediate and substantial dilution upon the closing of the Initial
public Offering, assuming no value is ascribed to the warrants included in the Units. Further, the ClassA ordinary shares issuable
in connection with the conversion of the Founder Shares may result in material dilution to our Public Shareholders due to the anti-dilution
rights of our Founder Shares that may result in an issuance of ClassA ordinary shares on a greater than one-to-one basis upon conversion.
Additionally, our Public Shareholders may have experienced dilution from the 430,000 Private Placement Units purchased by our Sponsor
in the Private Placement, as well as conversion of any working capital loans into equity, if elected by the Sponsor or by another person
or entity who made such working capital loans. 
2
The Founder Shares will automatically convert
into ClassA ordinary shares concurrently with or immediately following the consummation of our initial Business Combination, or
at any time prior thereto at the option of the holder thereof, on a one-for-one basis, subject to adjustment as provided herein. In the
case that additional ClassA ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold
in the Initial Public Offering and related to the closing of our initial Business Combination, the ratio at which ClassB ordinary
shares shall convert into ClassA ordinary shares will be adjusted (unless the holders of a majority of the outstanding ClassB
ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number
of ClassA ordinary shares issuable upon conversion of all ClassB ordinary shares will equal, in the aggregate, on an as-converted
basis, 20% of sum of (i)the total number of all ClassA ordinary shares outstanding upon the completion of the Initial Public
Offering (including any ClassA ordinary shares issued pursuant to the Underwriters over-allotment option and excluding the
ClassA ordinary shares underlying the Private Placement Units issued to the Sponsor), plus (ii)all ClassA ordinary shares
and equity-linked securities issued or deemed issued (on an as-converted basis), in connection with the closing of the initial Business
Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination
and any private placement-equivalent warrants issued to our Sponsor or any of its affiliates or to our officers or directors upon conversion
of working capital loans) minus (iii)any redemptions of ClassA ordinary shares by Public Shareholders in connection with an
initial Business Combination; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Our Public
Shareholders may incur material dilution due to such anti-dilution adjustments that result in the issuance of ClassA ordinary shares
on a greater than one-to-one basis upon conversion.
If we raise additional funds through equity or
convertible debt issuances, our Public Shareholders may suffer significant dilution. This dilution would increase to the extent that the
anti-dilution provision of the Founder Shares result in the issuance of Class A ordinary shares on a greater than one-to-one basis upon
conversion of the Founder Shares at the time of our initial Business Combination. In addition, the cashless exercise of the Private Placement
Units would further increase the dilution to our Public Shareholders.
In order to facilitate our initial Business Combination
or for any other reason determined by our Sponsor in its sole discretion, our Sponsor may surrender or forfeit, transfer or exchange our
Founder Shares, Private Placement Units or any of our other securities, including for no consideration, as well as subject any such securities
to earn-outs or other restrictions, or otherwise amend the terms of any such securities or enter into any other arrangements with respect
to any such securities. Except in certain limited circumstances, no member of the Sponsor may transfer all or any portion of its membership
units in the Sponsor. We may also issue Class A ordinary shares upon conversion of the Class B ordinary shares at a ratio greater than
one-to-one at the time of our initial Business Combination as a result of the anti-dilution provisions as set forth therein.
Pursuant to the Letter Agreement, each of our
Sponsor, directors and officers has agreed to restrictions on its ability to transfer, assign, or sell the Founder Shares and Private
Placement Units, as summarized in the IPO Registration Statement on Form S-1. They have also agreed to certain lock-up restrictions on
their ability to transfer, assign, or sell the Founder Shares and Private Placement Units and Class A ordinary shares underlying the Private
Placement Units. Further, the Sponsor membership interests (including the interests held by the non-managing members) are locked up and
not transferable because the letter agreement prohibits indirect transfers. They have also waived their rights to distributions from the
Trust Account with respect to any Founder Shares held by them if we fail to complete our initial Business Combination within the Combination
Period.
While there is no current intention to do so,
we may approve an amendment or waiver of the Letter Agreement that would allow the Sponsor to directly, or members of our Sponsor to indirectly,
transfer Founder Shares and Private Placement Units or membership interests in our Sponsor in a transaction in which the sponsor removes
itself as our Sponsor before identifying a Business Combination. As a result, there is a risk that our Sponsor and our officers and directors
may divest their ownership or economic interests in our Sponsor, which would likely result in our loss of certain key personnel, including
Mr. Pompliano. There can be no assurance that any replacement sponsor or key personnel will successfully identify a Business Combination
target for us, or, even if one is so identified, successfully complete such Business Combination.
The securities held by the Sponsor are only be
distributed directly to the members of the Sponsor in connection with or following the consummation of our initial Business Combination.
Indirect transfers of the securities held by the Sponsor, such as to another member of the Sponsor or their affiliate, a family member
or a new member of the Sponsor, may be permitted with the prior consent of Mr.Pompliano, as the controlling member of Inflection
Points, Inc. d/b/a Professional Capital Management, which is the sole managing member of our Sponsor, as long as such transfer complies
with the applicable transfer restrictions with respect to such securities to the same extent as the party originally subject to such restrictions.
3
While members of the Sponsor who are not our officers
and directors are not a direct party to the Letter Agreement, as a result of their ownership of membership interests in the Sponsor, they
are bound by the restrictions set forth above with respect to their allocated Founder Shares, the Private Placement Units and Class A
ordinary shares underlying the Private Placement Units (including the restriction on transfer of their membership interests because the
Letter Agreement prohibits indirect transfers).
Business Strategy
We believe that there are a range of target businesses
that could benefit from our industry knowledge, relationships, capital and public vehicle. Legacy financial firms, including those which
make up the largest ETF issuers in the world, have very small online followings. This makes it difficult for these firms to communicate
directly to the wealthy self-directed investors they are now targeting. Our strategy is to capitalize on the significant experience, network
and reach of Anthony Pompliano, our Chief Executive Officer, along with our directors and Special Advisor to identify and complete our
initial Business Combination with a target business that we can introduce to a large and growing customer base and generative much more
value in the future. Our focus will be on the financial services sector. While we intend to initially focus on potential opportunities
in the UnitedStates, we may pursue opportunities internationally.
Our Management Team plans to identify and contact
potential target businesses and start to evaluate and pursue a possible Business Combination. In addition, we will communicate the parameters
of our search to our network of relationships and transaction sources to help us identify potential target businesses. We intend to leverage
our teams collective experience in the financial services industry and capital markets to successfully complete a Business Combination,
and then continue to support our target business with our industry relationships, insights and regulatory knowledge, financial expertise
and capital resources.
Competitive Strengths
We believe that our Management Team is well positioned
to identify attractive target businesses within the financial technology industry and to facilitate a successful Business Combination
for the following reasons:
| 
| Experience recognizing key trends in the financial
services industry:Mr.Pompliano has a unique mix of legacy finance legitimacy (managed money on
behalf of public pensions/foundations/endowments and appears as a regular guest on CNBC/Bloomberg) and a large social media following
(1.6million Twitter followers, 558,000 YouTube subscribers, 260,000 newsletter subscribers). We believe this positions Mr.Pompliano
well to disrupt the traditional financial market with social media and awareness of key, emerging trends in the financial sector. | 
|
| 
| Experience identifying strong Management Teams:With
key members of our team having had significant senior executive roles at both public and private companies, we believe we have an ability
to identify the characteristics of successful business leaders, and effective in engaging with these Management Teams. In addition, key
members of our team have more recently been investing in many founder-led businesses. | 
|
| 
| History of operating experience:The
members of our team are seasoned operators having held executive level roles in various companies. We have experience in developing and
executing strategy, building and retaining teams, and executing mergers, acquisitions and Business Combinations among other activities. | 
|
| 
| Deep network and connections to company founders:Our
team has many connections to company founders and business leaders across sectors within the financial services industry. We have invested
in many companies, served on many boards and have worked with many influential founders and senior Management Teams within the financial
services industry, and specifically the sectors we intend to initially focus on. | 
|
| 
| Prior SPAC Experience:Our
Special Advisor, Brent Saunders, was the CEO and Chairman of Vesper Healthcare Acquisition Corp. which completed its Business Combination
with The Beauty Health Company (NASDAQ:SKIN) in May2021. The transaction raised approximately $780million of capital
through a combination of trust retention and common equity PIPE. | 
|
4
Investment Criteria
We intend to leverage the extensive network and
experience of our Management Team in identifying a suitable target within the financial services industry and structuring a Business Combination
that is attractive to both the target and our Public Shareholders. We have identified the following general criteria and guidelines that
we believe are important in evaluating prospective target businesses. While we intend to use these criteria and guidelines in evaluating
prospective businesses, we may deviate from these criteria and guidelines should we see fit to do so:
| 
| Clear and Sustainable Competitive Advantages:We
intend to target businesses that differentiate themselves from their peers in ways that are difficult to replicate and have clear competitive
advantages. | 
|
| 
| High Growth Potential and Cash Flow:We
intend to seek businesses that are well positioned to grow in their respective markets and which have clear plans on how to leverage
additional capital to accelerate growth. We expect to target businesses that have had, or expect to have, strong cash flow generation. | 
|
| 
| Experienced Management Teams:We
intend to seek to target businesses that have strong, experienced Management Teams who we believe may benefit from our financial, managerial
and investment expertise as well as our extensive industry networks and insights. We believe that identifying such Management Teams is
particularly important given our target industry. | 
|
| 
| Attractive Valuations:We
intend to only evaluate a business that, based on our due diligence and industry experience, represents an attractive valuation relative
to publicly listed companies with similar characteristics or in similar industry segments. | 
|
**
| 
| Will Benefit from Being a Public Company:We
intend to pursue a business that will benefit from being a public company, including potentially having broader access to capital and
a public currency for acquisitions. | 
|
These criteria are not intended to be exhaustive.
Any evaluation relating to the merits of a particular initial Business Combination may be based, to the extent relevant, on these general
guidelines as well as other considerations, factors and criteria that our Management may deem relevant. We may decide to enter into our
initial Business Combination with a target business that does not meet the above criteria and guidelines, and in the event we do so, we
will disclose that the target business does not meet the above criteria in our shareholder communications related to our initial Business
Combination, which, as discussed in this Report, would be in the form of proxy solicitation materials or tender offer documents that we
would file with the SEC.
Our Acquisition Process
In evaluating a prospective target business, we
expect to conduct a due diligence review which may encompass, among other things, meetings with incumbent management and employees, document
reviews, interviews of customers and suppliers, inspection of facilities, as applicable, as well as a review of financial, operational,
legal and other information about the target and its industry which will be made available to us. If we determine to move forward with
a particular target, we will proceed to structure and negotiate the terms of the Business Combination transaction.
The time required to select and evaluate a target
business and to structure and complete our initial Business Combination, and the costs associated with this process, are not currently
ascertainable with any degree of certainty. Any costs incurred with respect to the identification and evaluation of, and negotiation with,
a prospective target business with which our initial Business Combination is not ultimately completed will result in our incurring losses
and will reduce the funds available for us to use to complete another Business Combination.
Initial Business Combination
The Nasdaq Rules require that we must complete
one or more Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account
(excluding the deferred underwriting fee and taxes payable on the interest earned on the Trust Account, if any) (the 80% Test).
Our Board of Directors will make the determination as to the fair market value of our initial Business Combination. If our Board of Directors
is not able to independently determine the fair market value of our initial Business Combination, we will obtain an opinion from an independent
investment banking firm or another independent entity that commonly renders valuation opinions with respect to the satisfaction of such
criteria. While we consider it likely that our Board of Directors will be able to make an independent determination of the fair market
value of our initial Business Combination, it may be unable to do so if it is less familiar or experienced with the business of a particular
target or if there is a significant amount of uncertainty as to the value of the targets assets or prospects. Additionally, pursuant
to the Nasdaq Rules, any initial Business Combination must be approved by a majority of our independent directors.
5
We anticipate structuring our initial Business
Combination so that the post-transaction company in which our Public Shareholders own shares will own or acquire 100% of the equity interests
or assets of the target business or businesses. We may, however, structure our initial Business Combination such that the post-transaction
company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the
target Management Team or shareholders or for other reasons, but we will only complete such Business Combination if the post transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in
the target sufficient for it not to be required to register as an investment company under the Investment Company Act. Even if the post-transaction
company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the Business Combination may collectively
own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the Business Combination.
For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding
capital stock, shares or other equity interests of a target. In this case, we would acquire a 100% controlling interest in the target.
However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to our initial Business
Combination could own less than a majority of our issued and outstanding shares subsequent to our initial Business Combination. If less
than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post transaction company,
the portion of such business or businesses that is owned or acquired is what will be taken into account for purposes of the 80% Test described
above. If the Business Combination involves more than one target business, the 80% Test will be based on the aggregate value of all of
the target businesses.
Members of our Management Team and our independent
directors directly or indirectly own Founder Shares and/or Private Placement Units after the Initial Public Offering and, accordingly,
may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate
our initial Business Combination. The low price that our Sponsor, executive officers and directors (directly or indirectly) paid for the
Founder Shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an
acquisition target that subsequently declines in value and is unprofitable for Public Shareholders. If we are unable to complete our initial
Business Combination within the Combination Period, the Founder Shares and Private Placement Units may expire worthless, except to the
extent they receive liquidating distributions from assets outside the Trust Account, which could create an incentive for our Sponsor,
executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value
and is unprofitable for Public Shareholders. Further, each of our officers and directors may have a conflict of interest with respect
to evaluating a particular Business Combination if the retention or resignation of any such officers and directors was included by a target
business as a condition to any agreement with respect to our initial Business Combination.
Each of our officers and directors presently has,
and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities
pursuant to which such officer or director is or will be required to present a Business Combination opportunity to such entities. Accordingly,
if any of our officers or directors becomes aware of a Business Combination opportunity that is suitable for an entity to which he or
she has then current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present
such Business Combination opportunity to such other entity, subject to their fiduciary duties under Cayman Islands law. Our Amended and
Restated Charter provides that, to the fullest extent permitted by law: (i) no individual serving as a director or an officer, among other
persons, shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly
in the same or similar business activities or lines of business as us, and (ii) we renounce any interest or expectancy in, or in being
offered an opportunity to participate in, any potential transaction or matter which (a) may be a corporate opportunity for any director
or officer, on the one hand, and us, on the other or (b) the presentation of which would breach an existing legal obligation of a director
or officer to any other entity. As a result, the fiduciary duties or contractual obligations of our officers or directors could materially
affect our ability to complete our initial Business Combination.
In addition, our Sponsor and our officers and
directors may sponsor or form other SPACs similar to ours or may pursue other business or investment ventures during the period in which
we are seeking an initial Business Combination. As a result, our Sponsor, officers and directors could have conflicts of interest in determining
whether to present Business Combination opportunities to us or to any other SPACs with which they may become involved. Any such companies,
businesses or investments may present additional conflicts of interest in pursuing an initial Business Combination target. However, we
do not believe that any such potential conflicts would materially affect our ability to complete our initial Business Combination.
6
Status as a Public Company
We believe our structure makes us an attractive
Business Combination partner to target businesses. As an existing public company, we offer a target business an alternative to the traditional
initial public offering through a merger or other Business Combination with us. In a Business Combination transaction with us, the owners
of the target business may, for example, exchange their shares of stock or shares in the target business for our Class A ordinary shares
(or shares of a new holding company) or for a combination of our Class A ordinary shares and cash, allowing us to tailor the consideration
to the specific needs of the sellers. We believe target businesses will find this method a more expeditious and cost effective method
to becoming a public company than the typical initial public offering. The typical initial public offering process takes a significantly
longer period of time than the typical Business Combination transaction process, and there are significant expenses and market and other
uncertainties in the initial public offering process, including underwriting discounts and commissions, marketing and road show efforts
that may not be present to the same extent in connection with a Business Combination with us.
Furthermore, once a proposed initial Business
Combination is completed, the target business will have effectively become public, whereas an Initial Public Offering is always subject
to the Underwriters ability to complete the offering, as well as general market conditions, which could delay or prevent the offering
from occurring or could have negative valuation consequences. Following an initial Business Combination, we believe the target business
would then have greater access to capital, an additional means of providing management incentives consistent with shareholders
interests and the ability to use its shares as currency for acquisitions. Being a public company can offer further benefits by augmenting
a companys profile among potential new customers and vendors and aid in attracting talented employees.
While we believe that our structure and our Management
Teams backgrounds make us an attractive business partner, some potential target businesses may view our status as a blank check
company, such as our lack of an operating history and our ability to seek shareholder approval of any proposed initial Business Combination,
negatively.
Financial Position
With funds available for a Business Combination,
as of December 31, 2025, in the amount of $256,108,053 (not including amounts held outside of the Trust Account for working capital),
before payment of $11,250,000 of the deferred underwriting fees and taxes payable, if any, we offer a target business a variety of options,
such as creating a liquidity event for its owners, providing capital for the potential growth and expansion of its operations or strengthening
its balance sheet by reducing its debt ratio. Because we are able to complete our initial Business Combination using our cash, debt or
equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that we believe will
allow us to tailor the consideration to be paid to the target business to fit its needs and desires. However, we have not taken any steps
to secure third party financing and there can be no assurance it will be available to us.
If our initial Business Combination is paid for
using equity or debt securities, or not all of the funds released from the Trust Account are used for payment of the consideration in
connection with our initial Business Combination or used for redemptions of our Public Shares, we may use the balance of the cash released
to us from the Trust Account following the closing for general corporate purposes, including for maintenance or expansion of operations
of the post-transaction company, the payment of principal or interest due on indebtedness incurred in completing our initial Business
Combination, to fund the purchase of other companies, or for working capital.
7
Potential Additional Financings
We may need to obtain additional financing to
complete our initial Business Combination, either because the transaction requires more cash than is available from the proceeds held
in our Trust Account or because we become obligated to redeem a significant number of our Public Shares upon completion of the Business
Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. If we raise
additional funds through equity or convertible debt issuances, our Public Shareholders may suffer significant dilution and these securities
could have rights that rank senior to our Public Shares. If we raise additional funds through the incurrence of indebtedness, such indebtedness
would have rights that are senior to our equity securities and could contain covenants that restrict our operations. Further, as described
above, due to the anti-dilution rights of our Founder Shares, our Public Shareholders may incur material dilution. In addition, we intend
to target businesses with enterprise values that are greater than we could acquire with the net proceeds of the Initial Public Offering
and the sale of the Private Placement Units, and, as a result, if the cash portion of the purchase price exceeds the amount available
from the Trust Account, net of amounts needed to satisfy any redemptions by Public Shareholders, we may be required to seek additional
financing to complete such proposed initial Business Combination. We may also obtain financing prior to the closing of our initial Business
Combination to fund our working capital needs and transaction costs in connection with our search for and completion of our initial Business
Combination. There is no limitation on our ability to raise funds through the issuance of equity or equity-linked securities or through
loans, advances or other indebtedness in connection with our initial Business Combination, including pursuant to forward purchase agreements
or backstop agreements we may enter into following the Initial Public Offering. Subject to compliance with applicable securities laws,
we would only complete such financing simultaneously with the completion of our initial Business Combination. If we are unable to complete
our initial Business Combination because we do not have sufficient funds available to us, we will be forced to liquidate the Trust Account.
In addition, following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in
order to meet our obligations.
Sources of Target Businesses
We anticipate that target business candidates
will be brought to our attention from various unaffiliated sources, including investment bankers and private investment funds. Target
businesses may be brought to our attention by such unaffiliated sources as a result of being solicited by us through calls or mailings.
These sources may also introduce us to target businesses in which they think we may be interested on an unsolicited basis, since many
of these sources will have read this Report or the prospectus of our Initial Public Offering and know what types of businesses we are
targeting. Our officers and directors, as well as their affiliates, may also bring to our attention target business candidates of which
they become aware through their business contacts as a result of formal or informal inquiries or discussions they may have, as well as
attending trade shows or conventions. In addition, we expect to receive a number of proprietary deal flow opportunities that would not
otherwise necessarily be available to us as a result of the track record and business relationships of our officers and directors. While
we do not presently anticipate engaging the services of professional firms or other individuals that specialize in business acquisitions
on any formal basis, we may engage these firms or other individuals in the future, in which event we may pay a finders fee, consulting
fee or other compensation to be determined in an arms length negotiation based on the terms of the transaction.
Prior to or in connection with the completion
of our initial Business Combination, there may be payment by us to our Sponsor, officers or directors, Special Advisor, or our or their
affiliates, of a finders fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the
completion of our initial business, which, if made prior to the completion of our initial Business Combination, will be paid from funds
held outside the Trust Account.
We will engage a finder only to the extent our
Management determines that the use of a finder may bring opportunities to us that may not otherwise be available to us or if finders approach
us on an unsolicited basis with a potential transaction that our Management determines is in our best interest to pursue. Payment of a
finders fee is customarily tied to completion of a transaction, in which case any such fee will be paid out of the funds held in
the Trust Account.
8
We are not prohibited from pursuing an initial
Business Combination with a company that is affiliated with our Sponsor, officers or directors or our Special Advisor, or completing the
Business Combination through a joint venture or other form of shared ownership with our Sponsor, officers or directors or our Special
Advisor. In the event we seek to complete our initial Business Combination with a company that is affiliated (as defined in our Amended
and Restated Charter) with our Sponsor (including its members), officers or directors, we, or a committee of independent directors, will
obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions,
stating that the consideration to be paid by us in such an initial Business Combination is fair to our Company from a financial point
of view. We are not required to obtain such an opinion in any other context.
Lack of Business Diversification 
For an indefinite period of time after the completion
of our initial Business Combination, the prospects for our success may depend entirely on the future performance of a single business.
Unlike other entities that have the resources to complete Business Combinations with multiple entities in one or several industries, it
is probable that we will not have the resources to diversify our operations and mitigate the risks of being in a single line of business.
By completing our initial Business Combination with only a single entity, our lack of diversification may:
| 
| subject us to negative economic,
competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which
we operate after our initial Business Combination, and | 
|
| 
| cause us to depend on the marketing
and sale of a single product or limited number of products or services. | 
|
Limited Ability to Evaluate the Targets
Management Team
Although we closely scrutinize the management
of a prospective target business when evaluating the desirability of effecting our initial Business Combination with that business, our
assessment of the target businesss management may not prove to be correct. In addition, the future management may not have the
necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role of members of our Management Team,
if any, in the target business cannot presently be stated with any certainty. The determination as to whether any of the members of our
Management Team will remain with the combined company will be made at the time of our initial Business Combination. While it is possible
that one or more of our directors will remain associated in some capacity with us following our initial Business Combination, it is unlikely
that any of them will devote their full efforts to our affairs subsequent to our initial Business Combination. Moreover, we cannot assure
our shareholders that members of our Management Team will have significant experience or knowledge relating to the operations of the particular
target business.
We cannot assure our shareholders that any of
our key personnel will remain in senior management or advisory positions with the combined company. The determination as to whether any
of our key personnel will remain with the combined company will be made in connection with our initial Business Combination.
Following a Business Combination, we may seek
to recruit additional managers to supplement the incumbent management of the target business. We cannot assure our shareholders that we
will have the ability to recruit additional managers, or that additional managers will have the requisite skills, knowledge or experience
necessary to enhance the incumbent management.
Shareholders May Not Have the Ability to Approve
Our Initial Business Combination
We may conduct redemptions without a shareholder
vote pursuant to the tender offer rules of the SEC subject to the provisions of our Amended and Restated Charter. However, we will seek
shareholder approval if it is required by law or applicable stock exchange rule, or we may decide to seek shareholder approval for business
or other reasons.
Under the Nasdaq Rules, shareholder approval would
be required for our initial Business Combination if, for example:
| 
| We issue Ordinary Shares that
will be equal to or in excess of 20% of the number of our Ordinary Shares then outstanding (other than in a public offering); | 
|
9
| 
| Any of our directors, officers
or substantial shareholders (as defined by the Nasdaq Rules) has a 5% or greater interest (or such persons collectively have a 10% or
greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential
issuance of Ordinary Shares could result in an increase in outstanding Ordinary Shares or voting power of 5% or more; or | 
|
| 
| The issuance or potential issuance
of Ordinary Shares will result in our undergoing a change of control. | 
|
The decision as to whether we will seek shareholder
approval of a proposed Business Combination in those instances in which shareholder approval is not required by applicable law or stock
exchange listing requirements will be made by us, solely in our discretion, and will be based on business and legal reasons, which include
a variety of factors, including, but not limited to: (i) the timing of the transaction, including in the event we determine shareholder
approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place us at
a disadvantage in the transaction or result in other additional burdens on the company; (ii) the expected cost of holding a shareholder
vote; (iii) the risk that the shareholders would fail to approve the proposed Business Combination; (iv) other time and budget constraints
of the Company; and (v) additional legal complexities of a proposed Business Combination that would be time-consuming and burdensome to
present to shareholders.
Permitted Purchases of Our Securities
If we seek shareholder approval of our initial
Business Combination and we do not conduct redemptions in connection with our initial Business Combination pursuant to the tender offer
rules, our Sponsor, directors, officers and Special Advisor and any of their affiliates may purchase Public Shares or Public Warrants
in privately negotiated transactions or in the open market either prior to or following the completion of our initial Business Combination,
although they are under no obligation or duty to do so. Such a purchase may include a contractual acknowledgment that such Public Shareholder,
although still the record holder of our Public Shares, is no longer the beneficial owner thereof and therefore agrees not to exercise
its redemption rights. In the event that our Sponsor, directors, officers or Special Advisor or any of their affiliates purchase Public
Shares in privately negotiated transactions from Public Shareholders who have already elected to exercise their redemption rights, such
selling shareholders would be required to revoke their prior elections to redeem their Public Shares. It is intended that, if Rule 10b-18
would apply to purchases by our Sponsor, directors, officers or Special Advisor or any of their affiliates, then such purchases will comply
with Rule 10b-18 under the Exchange Act, to the extent it applies, which provides a safe harbor for purchases made under certain conditions,
including with respect to timing, pricing and volume of purchases.
Additionally, at any time at or prior to our initial
Business Combination, subject to applicable securities laws (including with respect to material nonpublic information), our Sponsor, directors,
officers and Special Advisor and any of their affiliates may enter into transactions with investors and others to provide them with incentives
to acquire Public Shares, vote their Public Shares in favor of our initial Business Combination or not redeem their Public Shares. However,
they have no current commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for
any such transactions. None of the funds in the Trust Account will be used to purchase Public Shares or Public Warrants in such transactions.
The purpose of any such transactions could be
to (1) increase the likelihood of obtaining shareholder approval of the Business Combination, (2) reduce the number of Public Warrants
outstanding and/or increase the likelihood of approval on any matters submitted to the Public Warrant holders for approval in connection
with our initial Business Combination or (3) satisfy a closing condition in an agreement with a target that requires us to have a minimum
net worth or a certain amount of cash at the closing of our initial Business Combination, where it appears that such requirement would
otherwise not be met. Any such purchases of our securities may result in the completion of our initial Business Combination in circumstances
that may not otherwise have been possible. To the extent such securities are purchased, such public securities will be not be voted as
required by Tender Offers and Schedules Compliance and Disclosure Interpretations Question 166.01 promulgated by the SEC.
In addition, if such purchases are made, the public
float of our securities may be reduced and the number of beneficial holders of our securities may be reduced, which may
make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.
10
Our Sponsor, directors, officers, and Special
Advisor and any of their affiliates anticipate that they may identify the Public Shareholders with whom our Sponsor, directors, officers
or Special Advisor or any of their affiliates may pursue privately negotiated transactions by either the Public Shareholders contacting
us directly or by our receipt of redemption requests submitted by Public Shareholders (in the case of Public Shares) following our mailing
of proxy materials in connection with our initial Business Combination. To the extent that our Sponsor, directors, officers or Special
Advisor or any of their affiliates enter into a private transaction, they would identify and contact only potential selling or redeeming
Public Shareholders who have expressed their election to redeem their Public Shares for a pro rata share of the Trust Account or vote
against our initial Business Combination, whether or not such Public Shareholder has already submitted a proxy with respect to our initial
Business Combination, but only if such Public Shares have not already been voted at the general meeting related to our initial Business
Combination. Our Sponsor, directors, officers and Special Advisor and any of their affiliates will select from which Public Shareholders
to purchase Public Shares based on the negotiated price and number of Public Shares and any other factors that they may deem relevant,
and are restricted from purchasing Public Shares if such purchases do not comply with Regulation M under the Exchange Act and the other
federal securities laws.
Our Sponsor, directors, officers and Special Advisor
and any of their affiliates are restricted from making purchases of Public Shares if the purchases would violate Section 9(a)(2) or Rule
10b-5 of the Exchange Act. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the extent
such purchasers are subject to such reporting requirements. Additionally, in the event our Sponsor, directors, officers or Special Advisor
or any of their affiliates were to purchase Public Shares or Public Warrants from Public Shareholders, such purchases would be structured
in compliance with the requirements of Rule 14e-5 under the Exchange Act including, in pertinent part, through adherence to the following:
| 
| our registration statement/proxy
statement filed for our Business Combination transaction would disclose the possibility that our Sponsor, directors, officers or Special
Advisor or any of their affiliates may purchase shares, rights or warrants from Public Shareholders outside the redemption process, along
with the purpose of such purchases; | 
|
| 
| if our Sponsor, directors,
officers or Special Advisor or any of their affiliates were to purchase Public Shares or Public Warrants from Public Shareholders, they
would do so at a price no higher than the price offered through our redemption process; | 
|
| 
| our registration statement/proxy
statement filed for our Business Combination transaction would include a representation that any of our securities purchased by our Sponsor,
directors, officers or Special Advisor or any of their affiliates would not be voted in favor of approving the Business Combination transaction; | 
|
| 
| our Sponsor, directors, officers
or Special Advisor or any of their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire
and possess redemption rights, they would waive such rights; and | 
|
| 
| we would disclose in a Current
Report on Form 8-K, before our general meeting of shareholders to approve the Business Combination transaction, the following material
items: | 
|
| 
o | the amount of our securities
purchased outside of the redemption offer by our Sponsor, directors, officers or Special Advisor or any of their affiliates, along with
the purchase price; | 
|
| 
o | the purpose of the purchases
by our Sponsor, directors, officers or Special Advisor or any of their affiliates; | 
|
| 
o | the impact, if any, of the
purchases by our Sponsor, directors, officers or Special Advisor or any of their affiliates on the likelihood that the Business Combination
transaction will be approved; | 
|
| 
o | the identities of our security
holders who sold to our Sponsor, directors, officers or Special Advisor or any of their affiliates (if not purchased on the open market)
or the nature of our security holders (e.g., 5% security holders) who sold to our Sponsor, directors, officers or Special Advisor or
any of their affiliates; and | 
|
| 
o | the number of our securities
for which we have received redemption requests pursuant to our redemption offer. | 
|
11
Redemption Rights for Public Shareholders upon
Completion of Our Initial Business Combination
We will provide our Public Shareholders with the
opportunity to redeem all or a portion of their Public Shares upon the completion of our initial Business Combination at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation
of an initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable, if any), divided
by the number of then outstanding Public Shares, subject to the limitations and on the conditions described herein. As of December 31,
2025, the amount in the Trust Account was $256,108,053, or approximately $10.24 per Public Share (before taxes payable,
if any). The per share amount we will distribute to investors who properly redeem their Public Shares will not be reduced by the deferred
underwriting fee we will pay to the Underwriters of the Initial Public Offering.
Our Sponsor, officers and directors have entered
into the Letter Agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any Founder Shares
and Public Shares they may hold in connection with the completion of our initial Business Combination.
Manner of Conducting Redemptions
We will provide our Public Shareholders with the
opportunity to redeem all or a portion of their Public Shares upon the completion of our initial Business Combination either (i) in connection
with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision
as to whether we will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by us, solely
in our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction
would require us to seek shareholder approval under applicable law or stock exchange listing requirement or whether we were deemed to
be a foreign private issuer (which would require a tender offer rather than seeking shareholder approval under SEC rules). Asset acquisitions
and share purchases would not typically require shareholder approval while direct mergers with our Company (other than with a 90% subsidiary
of ours) and any transactions where we issue more than 20% of our issued and outstanding Ordinary Shares or seek to amend our Amended
and Restated Charter would require shareholder approval. So long as we obtain and maintain a listing for our securities on Nasdaq, we
will be required to comply with the Nasdaq Rules.
The requirement that we provide our Public Shareholders
with the opportunity to redeem their Public Shares by one of the two methods listed above are contained in provisions of our Amended and
Restated Charter and will apply whether or not we maintain our registration under the Exchange Act or our listing on Nasdaq. Such provisions
may be amended if approved by a Special Resolution, which requires the affirmative vote of at least two-thirds of the votes cast by such
shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of
the company, so long as we offer redemption in connection with such amendment.
If we provide our Public Shareholders with the
opportunity to redeem their Public Shares in connection with a general meeting, we will, pursuant to our Amended and Restated Charter:
| 
| conduct the redemptions in
conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and
not pursuant to the tender offer rules, and | 
|
| 
| file proxy materials with the
SEC. | 
|
12
In the event that we seek shareholder approval
of our initial Business Combination, we will distribute proxy materials and, in connection therewith, provide our Public Shareholders
with the redemption rights described above upon completion of the initial Business Combination.
If we seek shareholder approval, we will complete
our initial Business Combination only if we receive an Ordinary Resolution. A quorum for such meeting will be present if the holders of
at least one third of issued and outstanding Ordinary Shares entitled to vote at the meeting are represented in person or by proxy. Our
Sponsor, officers and directors will count toward this quorum and, pursuant to the Letter Agreement, our Sponsor, officers and directors
have agreed to vote their Founder Shares, shares underlying the Private Placement Units and any Public Shares purchased during or after
the Initial Public Offering (including in open market and privately-negotiated transactions, aside from shares they may purchase in compliance
with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving the Business Combination transaction)
in favor of our initial Business Combination. For purposes of seeking approval of an Ordinary Resolution, non-votes will have no effect
on the approval of our initial Business Combination once a quorum is obtained. As a result, if all issued and outstanding shares are voted
on a resolution to approve our initial Business Combination, in addition to our Initial Shareholders Founder Shares, if we would
require an Ordinary Resolution, we would need 9,160,001 Public Shares, or 36.64% of the 25,000,000 Public Shares issued and outstanding
as of the date of this Report, and if we would require a Special Resolution of two-thirds of our Ordinary Shares voted at the meeting,
we would need 14,440,001 Public Shares, or 57.76% of the 25,000,000 Public Shares issued and outstanding as of the date
of this Report, to be voted in favor of an initial Business Combination in order to have our initial Business Combination approved, assuming
all outstanding shares are voted and the parties to the letter agreement do not acquire any ClassA ordinary shares. If our initial
Business Combination is structured as a statutory merger or consolidation with another company under Cayman Islands law, the approval
of our initial Business Combination will require a Special Resolution. Assuming that only the holders of one-third of our issued and outstanding
ordinary shares, representing a quorum under our Amended and Restated Charter, vote their ordinary shares, regardless of whether such
vote pertains to an Ordinary Resolution or a Special Resolution of two-thirds of our Ordinary Shares voted at the meeting, we would not
need any Public Shares in addition to our Founder Shares to be voted in favor of an initial Business Combination in order to approve an
initial Business Combination. In addition, prior to the closing of our initial Business Combination, only holders of our ClassB
ordinary shares (i)have the right to appoint and remove directors prior to or in connection with the completion of our initial Business
Combination and (ii)are entitled to vote on continuing our Company in a jurisdiction outside the Cayman Islands (including any Special
Resolution required to amend our constitutional documents or to adopt new constitutional documents, in each case, as a result of our approving
a transfer by way of continuation in a jurisdiction outside the Cayman Islands). These quorum and voting thresholds, and the voting agreement
of our Sponsor, officers and directors, may make it more likely that we will consummate our initial Business Combination. Each Public
Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction, or whether
they do not vote or abstain from voting on the proposed transaction, or whether they were a Public Shareholder on the record date for
the general meeting held to approve the proposed transaction.
If a shareholder vote is not required and we do
not decide to hold a shareholder vote for business or other legal reasons, we will:
| 
| conduct the redemptions pursuant
to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and | 
|
| 
| file tender offer documents
with the SEC prior to completing our initial Business Combination which contain substantially the same financial and other information
about the initial Business Combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates
the solicitation of proxies. | 
|
In the event we conduct redemptions pursuant to
the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under the
Exchange Act, and we will not be permitted to complete our initial Business Combination until the expiration of the tender offer period.
In addition, the tender offer will be conditioned on Public Shareholders not tendering more than the number of Public Shares we are permitted
to redeem. If Public Shareholders tender more Public Shares than we have offered to purchase, we will withdraw the tender offer and not
complete the initial Business Combination.
13
Upon the public announcement of our initial Business
Combination, if we elect to conduct redemption pursuant to the tender offer rules, we or our Sponsor will terminate any plan established
in accordance with Rule 10b5-1 to purchase our Public Shares in the open market, in order to comply with Rule 14e-5 under the Exchange
Act.
We intend to require our Public Shareholders seeking
to exercise their redemption rights, whether they are record holders or hold their shares in street name, to, at the holders
option, either deliver their share certificates to our transfer agent or deliver their shares to our transfer agent electronically using
the DWAC (Deposit/Withdrawal At Custodian) system, prior to the date set forth in the proxy materials or tender offer documents,
as applicable. In the case of proxy materials, this date may be up to two business days prior to the scheduled vote on the proposal to
approve the initial Business Combination. In addition, if we conduct redemptions in connection with a shareholder vote, we intend to require
a Public Shareholder seeking redemption of its Public Shares to also submit a written request for redemption to our transfer agent two
business days prior to the scheduled vote in which the name of the beneficial owner of such Public Shares is included. The proxy materials
or tender offer documents, as applicable, that we will furnish to our Public Shareholders in connection with our initial Business Combination
will indicate whether we are requiring Public Shareholders to satisfy such delivery requirements. We believe that this will allow our
transfer agent to efficiently process any redemptions without the need for further communication or action from the redeeming Public Shareholders,
which could delay redemptions and result in additional administrative cost. If the proposed initial Business Combination is not approved
and we continue to search for a target company, we will promptly return any certificates or shares delivered by Public Shareholders who
elected to redeem their Public Shares.
Our proposed initial Business Combination may
impose a minimum cash requirement for (i) cash consideration to be paid to the target or its owners, (ii) cash for working capital or
other general corporate purposes or (iii) the retention of cash to satisfy other conditions. In the event the aggregate cash consideration
we would be required to pay for all Class A ordinary shares that are validly submitted for redemption plus any amount required to satisfy
cash conditions pursuant to the terms of the proposed initial Business Combination exceed the aggregate amount of cash available to us,
we will not complete the initial Business Combination or redeem any Public Shares, and all Public Shares submitted for redemption will
be returned to the holders thereof. We may, however, raise funds through the issuance of equity or equity-linked securities or through
loans, advances or other indebtedness in connection with our initial Business Combination.
Limitation on Redemption Upon Completion of
Our Initial Business Combination If We Seek Shareholder Approval
If we seek shareholder approval of our initial
Business Combination and we do not conduct redemptions in connection with our initial Business Combination pursuant to the tender offer
rules, our Amended and Restated Charter provides that a Public Shareholder, together with any affiliate of such shareholder or any other
person with whom such shareholder is acting in concert or as a group (as defined under Section 13 of the Exchange Act),
will be restricted from seeking redemption rights with respect to more than an aggregate of 15% of the shares sold in our Initial Public
Offering (the Excess Shares) without our prior consent. We believe this restriction will discourage shareholders from accumulating
large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights against a proposed
Business Combination as a means to force us or our Management to purchase their Public Shares at a significant premium to the then-current
market price or on other undesirable terms. Absent this provision, a Public Shareholder holding more than an aggregate of 15% of the Public
Shares sold in the Initial Public Offering could threaten to exercise its redemption rights if such Public Shareholders Public
Shares are not purchased by us, our Sponsor or our Management at a premium to the then-current market price or on other undesirable terms.
By limiting our Public Shareholders ability to redeem no more than 15% of the Public Shares sold in the Initial Public Offering
without our prior consent, we believe we are limiting the ability of a small group of shareholders to unreasonably attempt to block our
ability to complete our initial Business Combination, particularly in connection with a Business Combination with a target that requires
as a closing condition that we have a minimum net worth or a certain amount of cash.
However, we are not restricting our shareholders
ability to vote all of their Public Shares (including Excess Shares) for or against our initial Business Combination.
14
Delivering Share Certificates in Connection
with the Exercise of Redemption Rights
As described above, we intend to require our Public
Shareholders seeking to exercise their redemption rights, whether they are record holders or hold their Public Shares in street
name, to, at the holders option, either deliver their share certificates to our transfer agent or deliver their shares to
our transfer agent electronically using the DWAC system, prior to the date set forth in the proxy materials or tender offer documents,
as applicable. In the case of proxy materials, this date may be up to two business days prior to the scheduled vote on the proposal to
approve the initial Business Combination. In addition, if we conduct redemptions in connection with a shareholder vote, we intend to require
a Public Shareholder seeking redemption of its Public Shares to also submit a written request for redemption to our transfer agent two
business days prior to the scheduled vote in which the name of the beneficial owner of such Public Shares is included. The proxy materials
or tender offer documents, as applicable, that we will furnish to holders of our Public Shares in connection with our initial Business
Combination will indicate whether we are requiring Public Shareholders to satisfy such delivery requirements. Accordingly, a Public Shareholder
would have up to two business days prior to the scheduled vote on the initial Business Combination if we distribute proxy materials, or
from the time we send out our tender offer materials until the close of the tender offer period, as applicable, to submit or tender its
Public Shares if it wishes to seek to exercise its redemption rights. In the event that a shareholder fails to comply with these or any
other procedures disclosed in the proxy or tender offer materials, as applicable, its Public Shares may not be redeemed. Given the relatively
short exercise period, it is advisable for Public Shareholders to use electronic delivery of their Public Shares.
There is a nominal cost associated with the above-referenced
process and the act of certificating the Public Shares or delivering them through the DWAC system. The transfer agent will typically charge
the broker submitting or tendering shares a fee of approximately $100 and it would be up to the broker whether or not to pass this cost
on to the redeeming holder. However, this fee would be incurred regardless of whether or not we require Public Shareholders seeking to
exercise redemption rights to submit or tender their Public Shares. The need to deliver shares is a requirement of exercising redemption
rights regardless of the timing of when such delivery must be effectuated.
Any request to redeem such Public Shares, once
made, may be withdrawn at any time up to the date set forth in the proxy materials or tender offer documents, as applicable. Furthermore,
if a Public Shareholder delivered its certificate in connection with an election of redemption rights and subsequently decides prior to
the applicable date not to elect to exercise such rights, such Public Shareholder may simply request that the transfer agent return the
certificate (physically or electronically). It is anticipated that the funds to be distributed to holders of our Public Shares electing
to redeem their Public Shares will be distributed promptly after the completion of our initial Business Combination.
If our initial Business Combination is not approved
or completed for any reason, then our Public Shareholders who elected to exercise their redemption rights would not be entitled to redeem
their Public Shares for the applicable pro rata share of the Trust Account. In such case, we will promptly return any certificates delivered
by Public Shareholders who elected to redeem their Public Shares.
If our initial proposed Business Combination is
not completed, we may continue to try to complete a Business Combination with a different target until the end of the Combination Period,
as it may be extended.
Redemption of Public Shares and Liquidation
if No Initial Business Combination 
Our Amended and Restated Charter provides that
we will have only the duration of the Combination Period, as it may be extended, to complete our initial Business Combination. If we have
not completed our initial Business Combination within such time period, we will (i) cease all operations except for the purpose of winding
up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter (and subject to lawfully available funds therefor),
redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the funds held in the Trust Account (which interest shall be net of taxes and less up to $100,000 of interest to pay
dissolution expenses), divided by the number of then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders
rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board of Directors,
liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements
of other applicable law. There will be no redemption rights or liquidating distributions with respect to our Warrants, which will expire
worthless if we fail to complete our initial Business Combination within the Combination Period, as it may be extended.
15
Our Sponsor, officers and directors have entered
into a Letter Agreement with us, pursuant to which they have waived their rights to liquidating distributions from the Trust Account with
respect to any Founder Shares held by them if we fail to complete our initial Business Combination within the Combination Period, although
they will be entitled to liquidating distributions from assets outside the Trust Account. However, if our Sponsor or Management Team acquire
Public Shares after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect
to such Public Shares if we fail to complete our initial Business Combination within the allotted Combination Period.
Our Sponsor, officers and directors have agreed,
pursuant to a written agreement with us, that they will not propose any amendment to our Amended and Restated Charter (x) to modify the
substance or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of our
Public Shares if we do not complete our initial Business Combination within the Combination Period or (y) with respect to any other material
provisions relating to shareholders rights or pre-initial Business Combination activity, in each case unless we provide our Public
Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less
taxes payable, if any), divided by the number of then outstanding Public Shares.
We expect that all costs and expenses associated
with implementing our plan of dissolution, as well as payments to any creditors, will be funded from amounts remaining out of the $1,069,737
of proceeds held outside the Trust Account, as of December 31, 2025, although we cannot assure our shareholders that there
will be sufficient funds for such purpose. However, if those funds are not sufficient to cover the costs and expenses associated with
implementing our plan of dissolution, to the extent that there is any interest accrued in the Trust Account not required to pay income
taxes on interest income earned on the Trust Account balance, we may request the trustee to release to us an additional amount of up to
$100,000 of such accrued interest to pay those costs and expenses.
If we were to expend all of the net proceeds of
the Initial Public Offering and the sale of the Private Placement Units, other than the proceeds deposited in the Trust Account, and without
taking into account interest, if any, earned on the Trust Account, the per-share redemption amount received by shareholders upon our dissolution
would be the redemption price (the Redemption Price). The proceeds deposited in the Trust Account could, however, become
subject to the claims of our creditors, which would have higher priority than the claims of our Public Shareholders. We cannot assure
our shareholders that the actual per-share redemption amount received by shareholders will not be substantially less than the Redemption
Price. While we intend to pay such amounts, if any, we cannot assure our shareholders that we will have funds sufficient to pay or provide
for all creditors claims.
Although we seek to have all vendors, service
providers, prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title,
interest or claim of any kind in or to any monies held in the Trust Account for the benefit of our Public Shareholders, there is no guarantee
that they will execute such agreements or even if they execute such agreements that they would be prevented from bringing claims against
the Trust Account including but not limited to fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well
as claims challenging the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our
assets, including the funds held in the Trust Account. If any third party refuses to execute an agreement waiving such claims to the monies
held in the Trust Account, our Management will consider whether competitive alternatives are reasonably available to us and will only
enter into an agreement with such third party if Management believes that such third partys engagement would be in the best interests
of the Company under the circumstances. Examples of possible instances where we may engage a third party that refuses to execute a waiver
include the engagement of a third party consultant whose particular expertise or skills are believed by management to be significantly
superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider
willing to execute a waiver. MaloneBailey, LLP, our independent registered public accounting firm, and the underwriters of the Initial
Public Offering did not execute agreements with us waiving such claims to the monies held in the Trust Account. In addition, there is
no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations,
contracts or agreements with us and will not seek recourse against the Trust Account for any reason.
16
In order to protect the amounts held in the Trust
Account, our Sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or
products sold to us (except for the Companys independent auditors), or a prospective target business with which we have entered
into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds
in the Trust Account to below the lesser of (i)$10.00 per Public Share, and (ii)the actual amount per Public Share held in
the Trust Account as of the date of the liquidation of the rust Account, if less than $10.00 per Public Share, due to reductions in the
value of the trust assets, less income taxes payable, provided that such liability will not apply to any claims by a third party or prospective
target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable)
nor will it apply to any claims under our indemnity of the Underwriters of the Initial Public Offering against certain liabilities, including
liabilities under the Securities Act. However, we have not asked our Sponsor to reserve for such indemnification obligations, nor have
we independently verified whether our Sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our Sponsors
only assets are securities of our Company.
Therefore, we cannot assure our shareholders that
our Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account,
the funds available for our initial Business Combination and redemptions could be reduced to less than $10.00 per Public Share. In such
event, we may not be able to complete our initial Business Combination, and our Public Shareholders would receive such lesser amount per
share in connection with any redemption of their Public Shares. None of our officers or directors will indemnify us for claims by third
parties including, without limitation, claims by vendors and prospective target businesses.
In the event that the proceeds in the Trust Account
are reduced below the lesser of (i)$10.00 per Public Share and (ii)the actual amount per Public Share held in the Trust Account
as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share, due to reductions in the value of the trust
assets, in each case less income taxes payable, and our Sponsor asserts that it is unable to satisfy its indemnification obligations or
that it has no indemnification obligations related to a particular claim, our independent directors would determine whether to take legal
action against our Sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would
take legal action on our behalf against our Sponsor to enforce its indemnification obligations to us, it is possible that our independent
directors in exercising their business judgment may choose not to do so in any particular instance if, for example, the cost of such legal
action is deemed by the independent directors to be too high relative to the amount recoverable or if the independent directors determine
that a favorable outcome is not likely. Accordingly, we cannot assure our shareholders that due to claims of creditors the actual value
of the per-share Redemption Price will not be less than $10.00 per Public Share.
We will seek to reduce the possibility that our
Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective
target businesses or other entities with which we do business execute agreements with us waiving any right, title, interest or claim of
any kind in or to monies held in the Trust Account. Our Sponsor will also not be liable as to any claims under our indemnity of the Underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. As of December 31, 2025, we
had access up to approximately $1,575,000 with which to pay any such potential claims (including costs and expenses incurred in connection
with our liquidation, currently estimated to be no more than approximately $100,000). In the event that we liquidate and it is subsequently
determined that the reserve for claims and liabilities is insufficient, shareholders who received funds from our Trust Account could be
liable for claims made by creditors.
If we file a bankruptcy or insolvency petition
or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, the proceeds held in the Trust Account
could be subject to applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of
third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the Trust Account, we cannot
assure our shareholders we will be able to return $10.00 per Public Share, to our Public Shareholders. Additionally, if we file a bankruptcy
or insolvency petition or an involuntary bankruptcy or insolvency petition is filed against us that is not dismissed, any distributions
received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy/insolvency laws as either a preferential
transfer or a fraudulent conveyance, preference or disposition. As a result, a liquidator or bankruptcy or other
court could seek to recover some or all amounts received by our shareholders. Furthermore, our Board of Directors may be viewed as having
breached its fiduciary duty to us or our creditors and/or may have acted in bad faith, and thereby exposing itself and our Company to
claims of punitive damages, by paying Public Shareholders from the Trust Account prior to addressing the claims of creditors. We cannot
assure our shareholders that claims will not be brought against us for these reasons.
17
Our Public Shareholders are entitled to receive
funds from the Trust Account only (i)in the event of the redemption of our Public Shares if we do not complete our initial Business
Combination within the Combination Period, (ii)in connection with a shareholder vote to amend our Amended and Restated Charter (A)to
modify the substance or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem
100% of our Public Shares if we do not complete our initial Business Combination within the Combination Period or (B)with respect
to any other material provisions relating to shareholders rights or pre-initial Business Combination activity or (iii)if
they redeem their respective shares for cash upon the completion of our initial Business Combination, subject to applicable law and any
limitations (including but not limited to cash requirements) created by the terms of the proposed Business Combination. In no other circumstances
will a shareholder have any right or interest of any kind to or in the Trust Account. In the event we seek shareholder approval in connection
with our initial Business Combination, a shareholders voting in connection with the Business Combination alone will not result
in a shareholders redeeming its shares to us for an applicable pro rata share of the Trust Account. Such shareholder must have
also exercised its redemption rights described above. These provisions of our Amended and Restated Charter, like all provisions of our
Amended and Restated Charter, may be amended with a shareholder vote.
Competition
In identifying, evaluating and selecting a target
business for our initial Business Combination, we may encounter competition from other entities having a business objective similar to
ours, including other SPACs, private equity groups and leveraged buyout funds, public companies and operating businesses seeking strategic
acquisitions. Many of these entities are well established and have extensive experience identifying and effecting Business Combinations
directly or through affiliates. Moreover, many of these competitors possess similar or greater financial, technical, human and other resources
than us. Our ability to acquire larger target businesses will be limited by our available financial resources. This inherent limitation
gives others an advantage in pursuing the acquisition of a target business. Furthermore, our obligation to pay cash in connection with
our Public Shareholders who exercise their redemption rights may reduce the resources available to us for our initial Business Combination
and our issued and outstanding warrants, and the future dilution they potentially represent, may not be viewed favorably by certain target
businesses. Either of these factors may place us at a competitive disadvantage in successfully negotiating an initial Business Combination.
Employees
We currently have two officers: Mr.Pompliano
and Ms. Abbey. These individuals are not obligated to devote any specific number ofhours to our matters but they intend to devote
as much of their time as they deem necessary to our affairs until we have completed our initial Business Combination. The amount of time
they will devote in any time period will vary based on whether a target business has been selected for our initial Business Combination
and the stage of the Business Combination process we are in. We do not intend to have any full-time employees prior to the completion
of our initial Business Combination.
Periodic Reporting and Financial Information
We have registered our Units, ClassA ordinary
shares and warrants under the ExchangeAct and have reporting obligations, including the requirement that we file annual, quarterly
and current reports with the SEC.In accordance with the requirements of the ExchangeAct, our annual reports, including this
Report, contain financial statements audited and reported on by our independent registered public accountants.
We will provide shareholders with audited financial
statements of the prospective target business as part of the proxy solicitation materials or tender offer documents sent to shareholders
to assist them in assessing the target business. In all likelihood, these financial statements will need to be prepared in accordance
with, or reconciled to, GAAP or IFRS, depending on the circumstances, and the historical financial statements may be required to be audited
in accordance with the standards of the Public Company Accounting Oversight Board (the PCAOB).These financial statement
requirements may limit the pool of potential target businesses we may conduct an initial Business Combination with because some targets
may be unable to provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete
our initial Business Combination within the prescribed time frame. We cannot assure our shareholders that any particular target business
identified by us as a potential Business Combination candidate will have financial statements prepared in accordance with the requirements
outlined above, or that the potential target business will be able to prepare its financial statements in accordance with the requirements
outlined above. To the extent that these requirements cannot be met, we may not be able to acquire the proposed target business. While
this may limit the pool of potential Business Combination candidates, we do not believe that this limitation will be material.
18
We will be required to evaluate our internal control
procedures for the fiscal year ending December31, 2025 as required by the Sarbanes-Oxley Act. Only in the event we are deemed to
be a large accelerated filer or an accelerated filer, and no longer qualify as an emerging growth company, will we be required to have
our internal control procedures audited. A target business may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding
adequacy of their internal controls. The development of the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley
Act may increase the time and costs necessary to complete any such Business Combination.
We have filed a registration statement on Form8-A
with the SEC to voluntarily register our securities under Section12 of the ExchangeAct. As a result, we are subject to the
rules and regulations promulgated under the ExchangeAct. We have no current intention of filing a Form15 to suspend our reporting
or other obligations under the ExchangeAct prior or subsequent to the consummation of our initial Business Combination.
We are a Cayman Islands exempted company. Exempted
companies are Cayman Islands companies conducting business mainly outside the Cayman Islands and, as such, are exempted from complying
with certain provisions of the Companies Act. As an exempted company, we have applied for and received a tax exemption undertaking from
the Cayman Islands government that, in accordance with Section6 of the Tax Concessions Act (As Revised) of the Cayman Islands, for
a period of 30years from the date of the undertaking (being January6, 2025), no law which is enacted in the Cayman Islands
imposing any tax to be levied on profits, income, gains or appreciations will apply to us or our operations and, in addition, that no
tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable
(i)on or in respect of our shares, debentures or other obligations or (ii)by way of the withholding in whole or in part of
a payment of dividends or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other
sums due under a debenture or other obligation of us. We are an emerging growth company, as defined in Section2(a)of
the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited
to, not being required to comply with the auditor attestation requirements of Section404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding
a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the
prices of our securities may be more volatile.
In addition, Section107 of the JOBS Act
also provides that an emerging growth company can take advantage of the extended transition period provided in Section7(a)(2)(B)of
the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can
delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take
advantage of the benefits of this extended transition period.
We will remain an emerging growth company until
the earlier of (1)the lastday of the fiscal year (a)following the fifth anniversary of the completion of the Initial
Public Offering, (b)in which we have total annual gross revenue of at least $1.235billion, or (c)in which we are deemed
to be a large accelerated filer, which means the market value of our ClassA ordinary shares that are held by non-affiliates exceeds
$700million as of the prior June30, and (2)the date on which we have issued more than $1.0billion in non-convertible
debt during the prior three-year period.
Additionally, we are a smaller reporting
company as defined in Item10(f)(1)of RegulationS-K.Smaller reporting companies may take advantage of certain
reduced disclosure obligations, including, among other things, providing only twoyears of audited financial statements. We will
remain a smaller reporting company until the lastday of the fiscal year in which (1)the market value of our ClassA ordinary
shares held by non-affiliates equals or exceeds $250million as of the end of that years second fiscal quarter, or (2)our
annual revenues equaled or exceeded $100million during such completed fiscal year and the market value of our ClassA ordinary
shares held by non-affiliates exceeds $700million as of the end of that years second fiscal quarter.
19
Prior to the consummation of a Business Combination,
only holders of our Class B Ordinary Shares will have the right to vote on the appointment or removal of directors. As a result, Nasdaq
considers us to be a controlled company within the meaning of Nasdaq corporate governance standards. Under Nasdaq corporate
governance standards, a company of which more than 50% of the voting power for the appointment of directors is held by an individual,
group or another company is a controlled company and may elect not to comply with certain corporate governance requirements.
We currently do not intend to rely on the controlled company exemption, but may do so in the future. Accordingly, if we
choose to do so, our shareholders will not have the same protections afforded to shareholders of companies that are subject to all of
the Nasdaq corporate governance requirements.
Item 1A. Risk Factors.
As a smaller reporting company under Rule 12b-2
of the Exchange Act, we are not required to include risk factors in this Report. However, the following is a partial list of material
risks, uncertainties and other factors that could have a material effect on us and our operations:
| 
| we are a blank check company and an early-stage company with
no revenue or basis to evaluate our ability to select a suitable business target; | 
|
| 
| we may not be able to select
an appropriate target business or businesses and complete our initial Business Combination within the Combination Period; | 
|
| 
| our expectations around the
performance of a prospective target business or businesses may not be realized; | 
|
| 
| we may not be successful in
retaining or recruiting required officers, key employees or directors following our initial Business Combination; | 
|
| 
| our officers and directors
may have difficulty allocating their time between our Company and other businesses and may potentially have conflicts of interest with
our business or in approving our initial Business Combination; | 
|
| 
| we may not be able to obtain
additional financing to complete our initial Business Combination or reduce the number of Public Shareholders requesting redemption; | 
|
| 
| we may issue our Ordinary Shares
to investors in connection with our initial Business Combination at a price that is less than the prevailing market price of our Ordinary
Shares at that time; | 
|
| 
| our shareholders may not be
given the opportunity to choose the initial Business Combination target or to vote on the initial Business Combination; | 
|
| 
| Trust Account funds may not
be protected against third-party claims or bankruptcy; | 
|
| 
| an active market for our public
securities may not continue and our shareholders may have limited liquidity and trading; | 
|
| 
| our financial performance following
a Business Combination with an entity may be negatively affected by their lack of an established record of revenue, cash flows and experienced
management; | 
|
| 
| there may be more competition
to find an attractive target for an initial Business Combination, which could increase the costs associated with completing our initial
Business Combination and may result in our inability to find a suitable target; | 
|
| 
| changes in the market for directors
and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial Business
Combination; | 
|
20
| 
| we may attempt to simultaneously
complete Business Combinations with multiple prospective targets, which may hinder our ability to complete our initial Business Combination
and give rise to increased costs and risks that could negatively impact our operations and profitability; | 
|
| 
| we may engage one or more of
the Underwriters of the Initial Public Offering or one of their respective affiliates to provide additional services to us after the
Initial Public Offering, which may include acting as a financial advisor in connection with an initial Business Combination or as placement
agent in connection with a related financing transaction. The Underwriters of the Initial Public Offering are entitled to receive the
deferred underwriting fee that will be released from the Trust Account only upon completion of an initial Business Combination. These
financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us after the
Initial Public Offering, including, for example, in connection with the sourcing and consummation of an initial Business Combination; | 
|
| 
| we may attempt to complete
our initial Business Combination with a private company about which little information is available, which may result in a Business Combination
with a company that is not as profitable as we suspected, if at all; | 
|
| 
| since our Sponsor will lose
its entire investment in us if our initial Business Combination is not completed (other than with respect to any Public Shares they may
acquire during or after the Initial Public Offering), and because our Sponsor, officers and directors may profit substantially even under
circumstances in which our Public Shareholders would experience losses in connection with their investment, a conflict of interest may
arise in determining whether a particular Business Combination target is appropriate for our initial Business Combination; | 
|
| 
| the value of the Founder Shares
following completion of our initial Business Combination is likely to be substantially higher than the nominal price paid for them, even
if the trading price of our Public Shares at such time is substantially less than the Redemption Price; | 
|
| 
| resources could be wasted in
researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or
merge with another business. If we have not completed our initial Business Combination within the Combination Period, our Public Shareholders
may receive only the Redemption Price or less than such amount in certain circumstances, on the liquidation of our Trust Account and
our Warrants will expire worthless; | 
|
| 
| we may not be able to complete
an initial Business Combination with certain potential target companies if a proposed transaction with the target company may be subject
to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations, including the Committee on Foreign
Investment in the United States (CFIUS). While our Sponsor is a limited liability company formed in Delaware and is not
controlled by, nor does it have substantial ties with, a non-U.S. person, it has two passive minority members that are from exempted
foreign states and one passive minority member from the United Arab Emirates. Investments that result in control of a U.S.
business by a foreign person are always subject to CFIUS jurisdiction; | 
|
| 
| recent fluctuations in inflation
and interest rates in the United States and elsewhere could make it more difficult for us to consummate an initial Business Combination; | 
|
| 
| adverse developments affecting
the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions,
could adversely affect our business, financial condition or results of operations, or our prospects; | 
|
| 
| military or other conflicts
in Ukraine, the Middle East or elsewhere may lead to increased volume and price volatility for publicly traded securities, or affect
the operations or financial condition of potential target companies, which could make it more difficult for us to consummate an initial
Business Combination; | 
|
| 
| if our initial Business Combination
involves a company organized under the laws of a state of the United States, it is possible the Excise Tax will be imposed on us in connection
with redemptions of our Ordinary Shares after or in connection with such initial Business Combination; | 
|
| 
| cyber incidents or attacks
directed at us or third parties could result in information theft, data corruption, operational disruption and/or financial loss; | 
|
| 
| changes in laws or regulations,
or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete
our initial Business Combination, and results of operations; | 
|
21
| 
| if we are deemed to be an investment
company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be
restricted, which may make it difficult for us to complete our initial Business Combination; and | 
|
| 
| to mitigate the risk that we
might be deemed to be an investment company for purposes of the Investment Company Act, we may, at any time (based on our Management
Teams ongoing assessment of all factors related to our potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in an interest-bearing demand
deposit account at a bank until the earlier of the consummation of our initial Business Combination or our liquidation. As a result of
such transfer, we could receive less interest on the funds held in the Trust Account than the interest we would have received pursuant
to our original Trust Account investments, which could reduce the dollar amount our Public Shareholders would receive upon any redemption
or our liquidation. | 
|
**
*We may seek to extend the Combination Period,
which could reduce the amount held in our Trust Account and have adverse effects on our Company.*
If we are unable to consummate our initial Business
Combination on or before May 22, 2027, we may seek shareholder approval to extend the Combination Period by amending our Amended and Restated
Charter. In such event, our Public Shareholders will be provided the opportunity to have all or a portion of their Public Shares redeemed.
Any redemptions will reduce the amount held in our Trust Account, the effect of which may adversely affect our ability to consummate our
initial Business Combination and may also impair our ability to maintain our Nasdaq listing.
**
*We anticipate that our securities will be
suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by May 22, 2027. Any trading suspension
or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to consummate
an initial Business Combination.*
Our IPO Registration Statement was declared effective
by the SEC on May 20, 2025 and our securities are currently listed on the Global Market tier of Nasdaq. Pursuant to our Amended and Restated
Charter, we have until May 22, 2027 to consummate our initial Business Combination. However, under the Nasdaq Rules, if a SPAC does not
meet the Nasdaq 36-Month Requirement, the SPAC will be subject to a suspension of trading and delisting from Nasdaq.
Under the Nasdaq Rules, a SPACs Nasdaq-listed
securities will be immediately suspended from trading if the SPAC does not meet the Nasdaq 36-Month Requirements, and Nasdaq will, at
such point, commence delisting procedures. Although a SPAC can request a hearing before the hearing panel of Nasdaq (the Hearing
Panel), the scope of the Hearing Panels review is limited. If a SPAC completes a Business Combination after receiving a
delisting determination by the staff of the Listing Qualifications Department of Nasdaq (a Staff Delisting Determination)
and/or demonstrates compliance with all applicable initial listing requirements, the combined company can apply to list its securities
on Nasdaq pursuant to the normal application review process. The Nasdaq Rules contain a list of deficiencies that would immediately result
in a Staff Delisting Determination, which includes noncompliance with the Nasdaq 36-Month Requirement. Accordingly, were we to amend our
Amended and Restated Charter to extend the date by which we are permitted to consummate our initial Business Combination, we would still
need to consummate our initial Business Combination on or prior to May 20, 2028 in order to avoid a suspension of our securities from
trading on and delisting from Nasdaq. If Nasdaq were to suspend our securities from trading and delist our securities, our securities
could potentially be quoted on an over-the-counter market. Even if our securities are then quoted on an over-the-counter market, our Nasdaq
suspension and delisting could have significant material adverse consequences, including:
| 
| 
| 
making our securities appear to be less attractive to potential target companies than the securities of an exchange listed SPAC; | |
| 
| 
| 
| |
| 
| 
| 
limited availability of market quotations for our securities; | |
22
| 
| 
| 
reduced liquidity for our securities; | |
| 
| 
| 
| |
| 
| 
| 
the possibility that our Class A ordinary shares would be deemed penny stock, which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; | |
| 
| 
| 
| |
| 
| 
| 
limited news and analyst coverage; and | |
| 
| 
| 
| |
| 
| 
| 
decreased ability to issue additional securities or obtain additional financing in the future. | |
In addition, if our securities are delisted from
Nasdaq, trading in our securities, and offers and sales of our securities by us, may be subject to state securities regulation and additional
compliance costs.
*The share price of the post-Business Combination
company may be less than the Redemption Price of our Public Shares.*
**
Each Unit sold in our Initial Public
Offering at an offering price of $10.00 per Unit consisted of one Public Share and one-half of one Public Warrant. Of the proceeds
we received from the Initial Public Offering and the Private Placement, $250,000,000 was placed in our Trust Account. We
will provide our Public Shareholders the opportunity to redeem all or a portion of their Public Shares in connection with the
completion of our initial Business Combination, and potentially upon the occurrence of certain other events prior to our initial
Business Combination. We expect that the pro rata redemption price in any redemption will be approximately $10.24
per Public Share as of December 31, 2025 (before taxes payable, if any), representing a pro rata portion of our Trust Account
without taking into account any interest or other income earned on such funds (less any withdrawals from such interest or income for
taxes paid), although the Redemption Price may be less in certain circumstances. As a result, Public Shareholders who own our Public
Shares on a redemption date can anticipate receiving the Redemption Price in connection with a redemption for each Public Share that
they choose to redeem.
There can be no assurance that, after our initial
Business Combination, our Public Shareholders would be able to sell their shares in the post-Business Combination company for the Redemption
Price, or any higher price. We have not as yet identified a target and are therefore unable to provide any assurances as to its financial
condition, business prospects or potential risks. It is therefore possible that the share price of the post-Business Combination company
may decline below the Redemption Price. In recent years, the share prices of many post-Business Combination companies have fallen following
a Business Combination. As a result, if our Public Shareholders continue to hold shares in the post-Business Combination company following
our initial Business Combination, we cannot assure our shareholders that the trading price of such shares will be greater than the Redemption
Price.
*Certain agreements related to the Initial
Public Offering may be amended, or their provisions waived, without shareholder approval.*
Certain of the agreements related to the Initial
Public Offering to which we are a party may be amended, or their provisions waived, without shareholder approval. Such agreements include,
among others, the (i) Underwriting Agreement, (ii) Letter Agreement, (iii) Registration Rights Agreement, (iii) Private Placement Units
Purchase Agreement and (iv) Administrative Services Agreement. These agreements contain various provisions that our Public Shareholders
might deem to be material. For example, our Letter Agreement and the Underwriting Agreement contain certain lock-up provisions with respect
to the Founder Shares and other securities held by our Sponsor, officers and directors, subject to certain exceptions. Amendments or waivers
to such agreements would require the consent of the applicable parties thereto and, in certain cases, the consent of the Underwriters
of the Initial Public Offering. Any such modification, such as an amendment to shorten lock-up restrictions, may benefit our Sponsor,
officers and/or directors. Any such amendments would not require approval from our shareholders, may result in the completion of our initial
Business Combination that may not otherwise have been possible, and may have an adverse effect on the value of an investment in our securities.
For example, although we would not amend lock-up provisions to permit securities held by our Sponsor to be freely sold, except to permitted
transferees, prior to our initial Business Combination, we may amend such provisions to permit them to be freely sold after the Business
Combination earlier than they would otherwise be permitted, which may have an adverse effect on the price of our securities. In no event,
however, will the Letter Agreement be amended to enable the Sponsor, officers or directors to redeem any of their Founder Shares from
the aggregate amount then on deposit in the Trust Account.
23
*Changes in international trade policies,
tariffs and treaties affecting imports and exports may have a material adverse effect on our search for an initial Business Combination
target or the performance or business prospects of a post-Business Combination company.*
**
There have recently been significant changes to
international trade policies and tariffs affecting imports and exports. Any significant increases in tariffs on goods or materials or
other changes in trade policy could negatively affect our search for a target and/or our ability to complete our initial Business Combination.
Recently, the United States has implemented a
range of new tariffs and increases to existing tariffs. In response to the tariffs announced by the United States, other countries have
imposed, are considering imposing, and may in the future impose new or increased tariffs on certain exports from the United States. There
is currently significant uncertainty about the future relationship between the United States and other countries with respect to trade
policies, taxes, government regulations and tariffs. and we cannot predict whether, and to what extent, current tariffs will continue
or trade policies will change in the future.
Tariffs, or the threat of tariffs or increased
tariffs, could have a significant negative impact on certain businesses (either due to domestic businesses reliance on imported
goods or dependence on access to foreign markets, or foreign businesses reliance on sales into the United States). In addition,
retaliatory tariffs could have a significant negative impact on foreign businesses that rely on imports from the United States, and domestic
businesses that rely on exporting goods internationally. These tariffs and threats of tariffs and other potential trade policy changes
could negatively affect the attractiveness of certain initial Business Combination targets, or lead to material adverse effects on a post-Business
Combination company. Among other things, historical financial performance of companies affected by trade policies and/or tariffs may not
provide useful guidance as to the future performance of such companies, because future financial performance of those companies may be
materially affected by new U.S. tariffs or foreign retaliatory tariffs, or other changes to trade policies. The business prospects of
a particular target for a Business Combination could change even after we enter into a Business Combination agreement, as a result of
tariffs or the threat of tariffs that may have a material impact on that targets business, and it may be costly or impractical
for us to terminate that Business Combination agreement. These factors could affect our selection of a Business Combination target.
We may not be able to adequately address the risks
presented by these tariffs or other potential trade policy changes. As a result, we may deem it costly, impractical or risky to complete
an initial Business Combination with a particular target or with a target in a particular industry or from a particular country. Consequently,
the pool of potential target companies may be reduced, which could impair our ability to identify a suitable target and to complete an
initial Business Combination. If we complete an initial Business Combination with such a target, the post-Business Combination companys
operations and financial results could be adversely affected as a result of tariffs or changes to trade policies, which may cause the
market value of the securities of the post-Business Combination company to decline.
**
*Delays in the government budget process
or a government shutdown may materially adversely affect our ability to complete an initial business combination, or the operations of
the combined company following our initial business combination.*
**
Each year, the U.S. Congress must pass all spending
bills in the federal budget. If any such spending bill is not timely passed, a government shutdown will close many federally run operations,
which includes those of the SEC, and halt work for federal employees unless they are considered essential. If a government shutdown were
to occur, and the SEC were to remain closed for a prolonged period of time, we may not be able to complete our initial business combination
within the time period as required by our amended and restated memorandum and articles of association (or such later date as may be approved
by our shareholders), particularly if the SEC is unable to timely review our filings, or those of a target business or other entity that
relate to our initial business combination, or to declare such filings effective as may be applicable. Additionally, following consummation
of our initial business combination, the combined companys operations or its ability to raise additional capital to support its
operations could be materially adversely affected by any prolonged government shutdown.
24
Item 1B. Unresolved Staff Comments.
Not applicable.
Item 1C. Cybersecurity.
Although, as a blank check company, we do not have any operations, we are nonetheless subject to the risk of cybersecurity incidents. Among other things, the investments in our Trust Account and bank deposits may be vulnerable to such incidents, and we may depend on the digital technologies of third parties. We and third parties may be subject to cybersecurity attacks or security breaches. To the extent that we rely on the technologies of third parties, we depend upon the personnel and the processes of such third parties to protect against cybersecurity incidents, and we have no personnel or processes of our own for this purpose. In the event of a cybersecurity incident impacting us, our Management Team will report to the Board of Directors and provide updates on the Management Teams incident response plan for addressing and mitigating any risks associated with such an incident. As an early-stage company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse consequences on our business and lead to financial loss. We have not encountered any cybersecurity incidents since our Initial Public Offering. In addition to our own cybersecurity risks, any proposed Business Combination target may have been subject to, or may in the future be subject to, cybersecurity incidents. 
Item 2. Properties.
Our executive offices are located at 600 Lexington
Ave, Floor2, NewYork, NY10022, and our telephone number is (305)938-0912. The cost for our use of this space is
included in the $10,000 per month fee we pay to an affiliate of our Sponsor for certain office space, utilities and secretarial and administrative
support, pursuant to the Administrative Services Agreement. We consider our current office space adequate for our current operations.
Item 3. Legal
Proceedings.
To the knowledge of our Management
Team, there is no material litigation currently pending or contemplated against us, any of our officers or directors in their capacity
as such or against any of our property.
Item 4. Mine Safety Disclosures.
Not applicable.
25
PART II
Item 5. Market for Registrants Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
| 
(a) | Market Information | 
|
Our Units, Public Shares and Public Warrants are
each traded on the Global Market tier of Nasdaq under the symbols PCAPU, PCAP
and PCAPW, respectively. Our Units commenced public trading on May 21, 2025,
and our Public Shares and Public Warrants commenced separate public trading on July 11, 2025.
| 
(b) | Holders | 
|
On March 12, 2026, there was one (1) holder of
record of our Units, one (1) holder of record of our Class A ordinary shares, one (1) holder of record of our Class B ordinary shares,
and one (1) holders of record of our Warrants.
| 
(c) | Dividends | 
|
We have not paid any cash dividends on our Ordinary
Shares to date and do not intend to pay cash dividends prior to the completion of our initial Business Combination. The payment of cash
dividends following completion of our initial Business Combination will be dependent upon our revenues and earnings, if any, capital requirements
and general financial condition subsequent to completion of our initial Business Combination. The payment of any cash dividends subsequent
to our initial Business Combination will be within the discretion of our Board of Directors at such time. In addition, our Board of Directors
is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any
indebtedness in connection with our initial Business Combination, our ability to declare dividends following completion of our initial
Business Combination may be limited by restrictive covenants we may agree to in connection therewith.
| 
(d) | Securities Authorized for
Issuance Under Equity Compensation Plans | 
|
None.
| 
(e) | Performance Graph | 
|
As a smaller reporting company, we are not required
to provide the information required by Regulation S-K Item 201(e).
| 
(f) | Recent Sales of Unregistered
Securities | 
|
Simultaneously with the closing of the Initial
Public Offering, the Company consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit,
in a private placement to the Sponsor, generating gross proceeds to the Company of $4,300,000. The Private Placement Units (and underlying
securities) are identical to the Units sold in the Initial Public Offering, except as otherwise disclosed in our IPO Registration Statement.
No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant
to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
| 
| 
(g) | 
Use of Proceeds from the Initial Public Offering | |
On May 22, 2025, we consummated our Initial Public
Offering of 25,000,000 Units, which includes the partial exercise by the Underwriters of their overallotment option in the amount of 3,000,000
Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Each Unit consists of one ClassA ordinary share and one-third
of one redeemable warrant, with each whole Warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per
share, subject to adjustment.
26
The Units were sold at a price of $10.00 per Unit,
generating gross proceeds to us of $250,000,000. Simultaneously with the consummation of our Initial Public Offering and pursuant to the
Private Placement Units Purchase Agreement, we completed the sale of 430,000 Private Placement Units at a price of $10.00 per Private
Placement Unit, in a private placement to our Sponsor, generating gross proceeds of $4,300,000. Each Private Placement Unit consists of
one Class A ordinary share and one-third of one redeemable warrant. Following the closing of our Initial Public Offering on May 22, 2025,
a total of $250,000,000 (which amount includes $11,250,000 of the deferred underwriting fee) was placed in a U.S.-based Trust Account
maintained by Odyssey Transfer and Trust Company, acting as trustee. The proceeds held in the Trust Account may be invested by the trustee
only in U.S. government securities with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury
obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. The Company may, at any time (based on Management
Teams ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing
demand deposit account at a bank. To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment
Company Act, which risk increases the longer that we hold investments in the Trust Account, we may, at any time (based on the Management
Teams ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee
to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest-bearing
demand deposit account at a bank.
Transaction costs amounted to $14,026,609, consisting
of $2,200,000 of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs.
The remaining proceeds from the Initial Public
Offering and the Private Placement are held outside the Trust Account. Such funds are being used primarily to enable us to identify a
target and to negotiate and consummate our initial Business Combination.
There has been no material change in the planned
use of the proceeds from our Initial Public Offering and the Private Placement as described in the IPO Registration Statement. The specific
investments in our Trust Account may change from time to time
| 
(h) | Purchases of Equity Securities
by the Issuer and Affiliated Purchasers | 
|
There were
no such repurchases of our equity securities by us or an affiliate during the fourth quarter of the fiscal year covered by the Report.
Item 6. [Reserved]
Item 7. Managements Discussion and Analysis
of Financial Condition and Results of Operations.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical
fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy
and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such
as anticipate, believe, estimate, expect, intend and similar expressions,
as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the beliefs
of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ
materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC.
All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety
by this paragraph.
The following discussion and analysis of our financial
condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere
in this Report.
Overview 
We are a blank check company incorporated in the
Cayman Islands on January 2, 2025 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share
purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination
using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Units, our shares, debt or a
combination of cash, shares and debt.
We expect to continue
to incur significant costs in the pursuit of our acquisition plans. We cannot assure our shareholders that our plans to complete a Business
Combination will be successful.
27
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from January 2, 2025 (inception) through December 31, 2025 were organizational activities,
those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination.
We do not expect to generate any operating revenues until after the completion of our Business Combination. Subsequent to the Initial
Public Offering, we generate non-operating income in the form of interest income on cash held in the Trust Account. We incur expenses
as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the period from January 2, 2025 (inception)
through December 31, 2025, we had net income of $5,659,179, which consisted of interest earned on cash held in Trust Account of $6,108,053
and a change in the fair value of the over-allotment option liability of $21,211, offset by general and administrative costs of $470,085.
Liquidity and Capital Resources
Until the consummation of the Initial Public Offering,
our only source of liquidity was an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor
and loans from the Sponsor.
On May 22, 2025, we consummated the Initial Public
Offering of 25,000,000 Units, which includes the partial exercise by the Underwriters of their over-allotment option in the amount of
3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Simultaneously with the closing of the Initial Public
Offering, we consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit, in a private placement
to the Sponsor, generating gross proceeds of $4,300,000.
Following the closing of the Initial Public Offering
and the private placement, a total of $250,000,000 was placed in the Trust Account. We incurred $14,026,609 in fees, consisting of $2,200,000
of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs.
For the period from January 2, 2025 (inception)
through December 31, 2025, cash used in operating activities was $486,104. The net income of $5,659,179 was affected by the following
non-cash and working capital items: interest income of $6,108,053 on cash held in the Trust Account, a $35,000 adjustment to accrued offering
costs, and a $21,211 change in the fair value of the over-allotment option liability. These were partially offset by $80,895 in general
and administrative expenses paid through the promissory note related party. Additionally, changes in operating assets and liabilities
used $61,914 in cash for operating activities.
We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete
our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our
Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the
target business or businesses, make other acquisitions and pursue our growth strategies.
We intend to use the funds held outside the Trust
Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel
to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate
documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of
such working capital loans may be convertible into Private Placement Units of the post Business Combination entity at a price of $10.00
per unit. The Units issued upon conversion of any such loans would be identical to the Private Placement Units sold in a private placement
concurrently with the Initial Public Offering.
28
We do not believe we will need to raise additional
funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target
business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so,
we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional
financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares
upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such
Business Combination.
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of December 31, 2025. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
**
Contractual Obligations 
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor an aggregate
of $10,000 per month for office space, utilities, management, operations, and secretarial and administrative support services.
The Underwriters were entitled to a deferred underwriting
discount of $11,250,000 (4.50% of the gross proceeds of the Initial Public Offering held in the Trust Account), payable upon the completion
of the Companys initial Business Combination subject to the terms of the Underwriting Agreement, but $0.10 per Unit of such $0.45
per Unit shall be due solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection
with the consummation of the initial Business Combination and $0.05 per Unit of such $0.45 per Unit shall be allocable by the Company.
Critical Accounting Estimates and Policies
The preparation of the financial statements and
related disclosures in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of
assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses
during the periods reported. Making estimates requires Management to exercise significant judgment. It is at least reasonably possible
that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements,
which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly,
the actual results could materially differ from those estimates. As of December 31, 2025, we did not have any critical accounting estimates
to be disclosed.
Item 7A. Quantitative and Qualitative Disclosures
about Market Risk 
We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.
29
Item 8. Financial Statements and Supplementary
Data
Reference is made to pages F-1 through F-17 comprising a portion of
this Annual Report on Form 10-K.
Item 9. Changes in and Disagreements with Accountants
on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SECs rules and forms, and that such information is accumulated and communicated to our
Management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15 under the
Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and
operation of our disclosure controls and procedures as of December 31, 2025. Based upon their evaluation, our Chief Executive Officer
and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) were not effective due to the material weakness of inadequate segregation of duties within account processes due to limited
personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.
We do not expect that our disclosure controls
and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and
operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits
must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation
of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances
of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Managements Report on Internal Controls
Over Financial Reporting
This Annual Report on Form 10-K does not include
a report of managements assessment regarding internal control over financial reporting or an attestation report of our independent
registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control
over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal
quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B. Other Information.
Trading Arrangements
During the quarterly period ended December 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408 of Regulation S-K. 
Additional Information
None.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not applicable.
30
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
Directors and Executive Officers
As of the date of this Report, our directors and
officers are as follows:
| 
Name | 
| 
Age | 
| 
Position | |
| 
Anthony J. Pompliano III | 
| 
37 | 
| 
Chief Executive Officer and Director | |
| 
Catalina Abbey | 
| 
44 | 
| 
Chief Financial Officer | |
| 
Michael Gonzalez | 
| 
37 | 
| 
Independent Director | |
| 
Lindsey Haswell | 
| 
48 | 
| 
Independent Director | |
| 
Ben Buchanan | 
| 
39 | 
| 
Independent Director | |
The experience of our directors and executive
officers is as follows:
Anthony J.PomplianoIII, our
Chief Executive Officer and Director of the Board since our formation on January2, 2025, is the controlling member of Inflection
Points, Inc. d/b/a Professional Capital Management, which is the sole managing member of our Sponsor ProCap Acquisition Sponsor, LLC.Mr.Pompliano
is the founder and has served as the Chief Executive Officer of Professional Capital Management since January2022. Professional
Capital Management is a global investment firm backed by leading venture capitalists and business executives. The organization leverages
a large social media following to create and acquire cash-flow positive businesses. The profits from the operating companies are then
invested across the public and private market. Prior to founding Professional Capital Management, he has been an entrepreneur and private
investor for more than 14years, having invested in more than 200 companies.
Mr.Pompliano currently hosts podcasts in
business and investing on The Pomp Podcast, while also writing a daily letter to 260,000+ investors each morning. Mr.Pompliano
was a co-founder and managing partner at Full Tilt Capital from 2016 until it was acquired by Morgan Creek Digital Assets in 2018. Mr.Pompliano
was a co-founder and managing partner of Morgan Creek Digital Assets from 2018 to 2020.
Prior to his investment career, Mr.Pompliano
ran product and growth teams at Facebook, and served as a sergeant in the US Army. Mr.Pompliano graduated from Bucknell University
with a degree in economics.
Catalina Abbey, our Chief Financial Officer,
has served as Chief Financial Officer since February2025. She has been the chief financial officer of APFO Inc.Family
Office and Professional Capital Management since October2022. During 2025, Ms. Abbey acted as Interim CFO for ProCap BTC, LLC and
ProCap Financial, Inc. during the de-SPAC transaction with Columbus Circle Capital Corp I. With 15years of experience, Ms. Abbey
specializes in evaluating, structuring, and executing mergers and acquisitions, supporting investment decisions, and driving financial
operations. Before assuming her current role, Ms. Abbey served as the Director of Finance at Grant Cardone Enterprises from October2020
to October2022. She also held the role of Director at Invoke LLC from February 2019 to October 2022, and served as Senior Vice President
of Finance for the U.S. and Europe at VVIG, Inc. from May 2015 to May 2019. Additionally, she worked as the Financial Executive for the
U.S. and Latin America at Envirotek Realty Group from August 2013 to May 2015. Ms. Abbey has also served as Executive Director for the
Colombia chapter and as a member of the Board of Directors for Ronald McDonald House Charities, while also supporting the financial development
of 8 Latin American chapters as a Finance Strategist from January 2011 to November 2013. Furthermore, she served as Head of Finance at
Bedigital Inc. from March 2010 to December 2011.
31
Ms. Abbey holds a Bachelors degree in Business
Administration from CESA School of Business, a Masters degree in Business Administration from Heriot-Watt UniversityEdinburgh
Business School, and a Masters degree in Accounting from Southern New Hampshire University. Other certifications held by Ms. Abbey
include Certified Management Accountant (CMA) and Certified in Strategy and Competitive Accounting (CSCA) designations.
Michael Gonzalez has served as an independent
director since May 2025. Since February 2025, Mr.Gonzalez has served as Senior Advisor to the U.S. Office of Personnel Management.
In May 2025, Mr. Gonzalez founded CFO AI, Inc., a private technology company. From December 2023 to December 2024, Mr. Gonzalez served
as the Director of Product Management, Office of CFO for Paylocity (NASDAQ: PCTY), following its acquisition of TraceHQ. From 2017 to
December 2023, Mr.Gonzalez served as the co-founder and CEO of TraceHQ.com, a workforce planning product. From 2017 to 2019, Mr.Gonzalez
served as a consulting CFO for Lattice, an artificial intelligence powered human resources platform. Prior to that, he served as Vice
President of Finance & Strategy at Zenefits from 2015 to 2017. Mr.Gonzalez earned a degree in Business, Finance from Indiana
University.
Lindsey Haswell has served as an independent
director since May 2025. Since February 2023, Ms. Haswell has served as the Chief Legal and Administrative Officer of MoonPay, a web3
and crypto payments company. Ms. Haswell also serves as a member of Blackrocks iShares Delaware Trust Sponsor LLC Board of Directors
and Audit Committee, which includes $IBIT, $ETHA, $GSG, $IAU, $IAUM, and $SLV. Prior to joining MoonPay, Ms. Haswell served as the Chief
Legal and Administrative Officer of Blockchain.com, a crypto-asset firm, from May 2021 to February 2023. Since July 2022, Ms. Haswell
has served on the founding team of the Core blockchain network, a Bitcoin-powered layer-one blockchain. From September 2018 to May 2021,
Ms. Haswell served as the Chief Legal and Administrative Officer of mobility company Lime, and was a founding member of Ubers Legal
Team, on which she served from January 2015 to November 2017. Ms. Haswell earned a degree in Political Science and Journalism from the
University of Southern California and a law degree from the University of Southern California.
Ben Buchanan has served as an independent
director since May 2025. Since January 2025, Mr.Buchanan has served as the Chief Executive Officer of All Current, a provider of
electrical solutions. From September 2019 to July 2022, Mr.Buchanan served as Chief Financial Officer for LindFast Solutions Group,
the leading master distributor of fasteners in North America. Mr.Buchanan then served as Executive Vice President and Chief Operating
Officer of LindFast Solutions Group from July 2022 to October 2024. Prior to his time at LindFast Solutions Group, Mr.Buchanan served
as the Chief Financial Officer of US Greenfiber, a cellulose insulation manufacturer, from July 2018 to August 2019. Additionally, Mr.Buchanan
has served on the board of directors of Argus Monitoring Solutions since February 2022. Mr.Buchanan earned a degree in Economics
from Samford University and an MBA from the University of Kentucky.
Our Advisor
Brenton L.Saundersis serving
as a Special Advisor to the Company. Mr.Saunders has served on the board of directors of TBHC since May4, 2021 and currently
serves as its chairman of the board. Mr.Saunders briefly served as Interim Chief Executive Officer of TBHC in January and February2022,
and as TBHCs executive chairman of the board of directors for the fiscal year of 2022 until March2023. Mr.Saunders
has over 25years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical
and healthcare companies. Until May2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63billion,
Mr.Saunders served as Chairman, President and Chief Executive Officer of Allergan plc (Allergan), an American, Irish-domiciled
pharmaceutical company. His role as president and chief executive officer of Allergan began in July2014 and his added role of chairman
began in October2016. Mr.Saunders first role as an executive officer in the pharmaceuticals and healthcare sectors
began in 2003, as a member of the executive Management Team at Schering-Plough Corporation (Schering-Plough), where he held
several key roles, including president of the companys Global Consumer Health Care division. While at Schering-Plough, Mr.Saunders
led the integrations of the companys $14billion acquisition of Organon Biosciences N.V. in 2007 as well as the merger between
Schering-Plough and Merck& Co., Inc. in 2009. From March2010 until August2013, Mr.Saunders served as Chief
Executive Officer of Bausch + Lomb Corporation, a leading global eye health company, until its acquisition by Valeant Pharmaceuticals,
Inc. in 2013. He then became the Chief Executive Officer of Forest Laboratories Inc., a role he held until the companys merger
with Actavis plc (Actavis) in 2014. Following the merger with Actavis, Mr.Saunders was named Chief Executive Officer
of the combined business. In 2015, he led Actavis acquisition of Allergan, renaming the post-combination company Allergan Plc.
32
Before joining Schering-Plough in 2003, Mr.Saunders
was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP, an international professional services company.
Prior to that, he was Chief Risk Officer at Coventry Health Care, Inc., a health insurance company, and Senior Vice President, Compliance,
Legal and Regulatory at Home Care Corporation of America, a healthcare service provider. Mr.Saunders began his career as Chief Compliance
Officer for the Thomas Jefferson University Health System.
Over the course of his career, Mr.Saunders
has overseen over 80 mergers, acquisitions, divestitures and licensing transactions, totaling over $300billion in value. Notable
highlights from Mr.Saunders transaction experience include Actavis approximately $28billion acquisition of Forest
Laboratories in 2014, Actavis $70billion acquisition of Allergan in 2015 and the $40billion sale of Allergans
global generics business to Teva Pharmaceutical Industries Ltd in 2016. Mr.Saunders transaction experience also includes
the divestiture of Allergans medical dermatology business, and the acquisitions of leading companies in the medical aesthetics
space such as Kythera, Lifecell, and Zeltiq. Additionally, as of March2023, Mr.Saunders rejoined Bausch + Lomb Corporation
and currently serves as its Chairman and CEO.
Our Special Advisor (i)assists us in sourcing
and negotiating with potential Business Combination targets, (ii)provides business insights when we assess potential Business Combination
targets and (iii)upon our request, provides business insights as we work to create additional value in the businesses that we acquire.
However, our Special Advisor has no written advisory agreement with us. Additionally, our Special Advisor has no other employment or compensation
arrangements with us. Moreover, our Special Advisor is not under any fiduciary obligations to us, does not perform board or committee
functions, and does not have any voting or decision-making capacity on our behalf. Our Special Advisor is also not be required to devote
any specific amount of time to our efforts. Accordingly, if our Special Advisor becomes aware of a Business Combination opportunity which
is suitable for any of the entities to which our Special Advisor has fiduciary or contractual obligations (including other blank check
companies), our Special Advisor will honor their fiduciary or contractual obligations to present such Business Combination opportunity
to such entity, and only present it to us if such entity rejects the opportunity. We may modify or expand our roster of advisors as we
source potential Business Combination targets or create value in businesses that we may acquire.
*Family Relationships*
No family relationships exist between any of our
directors, executive officers or Special Advisor.
*Involvement in Certain Legal Proceedings*
There are no material proceedings to which any
director or executive officer, or any associate of any such director or officer is a party adverse to our Company, or has a material interest
adverse to our Company.
Number and Terms of Office of Officers and Directors
Our Board of Directors consists of four members
and is divided into three classes with only one class of directors being appointed in each year, and with each class (except for those
directors appointed prior to our first annual general meeting) serving a three-year term. Prior to the closing of our initial Business
Combination, only holders of our ClassB ordinary shares will be entitled to vote on the appointment and removal of directors or
continuing the company in a jurisdiction outside the Cayman Islands (including any Special Resolution required to amend our constitutional
documents or to adopt new constitutional documents, in each case, as a result of our approving a transfer by way of continuation in a
jurisdiction outside the Cayman Islands). Holders of our Public Shares are not entitled to vote on such matters during such time. These
provisions of our Amended and Restated Charter relating to these rights of holders of ClassB ordinary shares may be amended by a
Special Resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation
of our initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or,
where proxies are allowed, by proxy at the applicable general meeting of the company. In accordance with Nasdaq corporate governance requirements,
we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on Nasdaq.
The term of office of the first class of directors, which consists of Mr.Gonzalez, will expire at our first annual general meeting.
The term of office of the second class of directors, which consists of Mr.Buchanan, will expire at the second annual general meeting.
The term of office of the third class of directors, which consists of Ms. Haswell and Mr.Pompliano, will expire at the third annual
general meeting.
33
Our officers are appointed by the Board of Directors
and serve at the discretion of the Board of Directors, rather than for specific terms of office. Our Board of Directors is authorized
to appoint officers as it deems appropriate pursuant to our Amended and Restated Charter.
Committees of the Board of Directors
Our Board of Directors has two standing committees:
the Audit Committee and a compensation committee (the Compensation Committee). Subject to phase-in rules, the Nasdaq Rules
and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors.
Each committee operates under a charter that has been approved by our Board and has the composition and responsibilities described below.
**
*Audit Committee*
We have established the Audit Committee of the
Board of Directors. Mr.Gonzalez, Ms. Haswell, and Mr.Buchanan serve as the members of our Audit Committee. Under the Nasdaq
Rules and applicable SEC rules, we are required to have three members of the Audit Committee, all of whom must be independent. Mr.Gonzalez,
Ms. Haswell, and Mr.Buchanan are each independent.
Mr.Buchanan serves as the chairman of the
audit committee. Each member of the audit committee is financially literate and our Board of Directors determined that Mr.Buchanan
qualifies as an audit committee financial expert as defined in applicable SEC rules.
We have adopted an audit committee charter, which
details the principal functions of the audit committee, including:
| 
| assisting Board oversight of (1)the integrity of our
financial statements, (2)our compliance with legal and regulatory requirements, (3)our independent registered public accounting
firms qualifications and independence, and (4)the performance of our internal audit function and independent registered
public accounting firm; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors
and any other independent registered public accounting firm engaged by us; | 
|
| 
| pre-approving all audit and non-audit services to be provided
by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval
policies and procedures; reviewing and discussing with the independent registered public accounting firm all relationships the independent
registered public accounting firm have with us in order to evaluate their continued independence; | 
|
| 
| setting clear policies for audit partner rotation in compliance
with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting
firm describing (1)the independent registered public accounting firms internal quality-control procedures and (2)any
material issues raised by the most recent internal quality-control review, or peer review, of the independent registered public accounting
firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding fiveyears respecting
one or more independent audits carried out by the firm and any steps taken to deal with such issues; | 
|
| 
| meeting to review and discuss our annual audited financial
statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing
our specific disclosures under Managements Discussion and Analysis of Financial Condition and Results of Operations;
reviewing and approving any related party transaction required to be disclosed pursuant to Item404 of RegulationS-K promulgated
by the SEC prior to us entering into such transaction; and | 
|
| 
| reviewing with management, the independent registered public
accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with
regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial
statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting
Standards Board, the SEC or other regulatory authorities. | 
|
34
**
*Compensation Committee*
We have established the Compensation Committee
of our Board of Directors. The members of our Compensation Committee are Ms. Haswell and Mr.Buchanan. Mr.Buchanan serves as
chair of the Compensation Committee. Under the Nasdaq Rules and applicable SEC rules, we are required to have a Compensation Committee
of at least two members, all of whom must be independent. Ms. Haswell and Mr.Buchanan are each independent.
We have adopted a compensation committee charter,
which details the principal functions of the compensation committee, including:
| 
| reviewing and approving on an annual basis the corporate
goals and objectives relevant to our chief executive officers compensation, evaluating our chief executive officers performance
in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer based on
such evaluation; | 
|
| 
| reviewing and making recommendations to our Board of Directors
with respect to the compensation, and any incentive compensation and equity based plans that are subject to Board approval of all of
our other officers; | 
|
| 
| reviewing our executive compensation policies and plans; | 
|
| 
| implementing and administering our incentive compensation
equity-based remuneration plans; | 
|
| 
| assisting management in complying with our proxy statement
and annual report disclosure requirements; | 
|
| 
| approving all special perquisites, special cash payments
and other special compensation and benefit arrangements for our executive officers and employees; | 
|
| 
| producing a report on executive compensation to be included
in our annual proxy statement; and | 
|
| 
| reviewing, evaluating and recommending changes, if appropriate,
to the remuneration for directors. | 
|
The charter also provides that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and is
directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving
advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence
of each such adviser, including the factors required by Nasdaq and the SEC.
Director Nominations
We do not have a standing nominating committee
though we would form a corporate governance and nominating committee as and when required to do so by law or the Nasdaq Rules. In accordance
with Rule 5605(e)(2) of the Nasdaq Rules, a majority of the independent directors may recommend a director nominee for selection by our
Board of Directors. Our Board of Directors believes that the independent directors can satisfactorily carry out the responsibility of
properly selecting or approving director nominees without the formation of a standing nominating committee. The directors who participate
in the consideration and recommendation of director nominees are Mr.Gonzalez, Ms. Haswell, and Mr.Buchanan. In accordance
with Rule 5605(e)(1)(A) of the Nasdaq Rules, all such directors are independent. As there is no standing nominating committee, we do not
have a nominating committee charter in place.
The Board of Directors also consider director
candidates recommended for nomination by our shareholders during such times as they are seeking proposed nominees to stand for appointment
at the next annual general meeting (or, if applicable, an extraordinary general meeting). Our shareholders that wish to nominate a director
for appointment to our Board of Directors should follow the procedures set forth in our Amended and Restated Charter.
35
We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, our Board of Directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom and the ability to represent the best interests of our shareholders.
Prior to our initial Business Combination, our Public Shareholders do not have the right to recommend director candidates for nomination
to our Board of Directors.
Code of Ethics
We have adopted a Code of Business Conduct and
Ethics, applicable to our directors, officers and employees (the Code of Ethics). A copy of the Code of Ethics and the charters
of the committees of our Board of Directors will be provided without charge upon request from us. If we make any amendments to our Code
of Ethics other than technical, administrative or other non-substantive amendments, or grant any waiver, including any implicit waiver,
from a provision of the Code of Ethics applicable to our principal executive officer, principal financial officer, principal accounting
officer or controller or persons performing similar functions requiring disclosure under applicable SEC rules or the Nasdaq Rules, we
will disclose the nature of such amendment or waiver on our website. The information included on our website is not incorporated by reference
into this Report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive
textual references only.
The foregoing description of the Code of Ethics
does not purport to be complete and is qualified in its entirety by the terms and conditions of the Code of Ethics, a copy of which is
attached hereto as Exhibit 14 and is incorporated herein by reference.
Trading Policies
On March 14, 2026, we adopted insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees, which are reasonably designed to promote compliance with insider trading laws, rules and regulations, and the applicable Nasdaq Rules (the Insider Trading Policy). 
The foregoing description of the Insider Trading
Policy does not purport to be complete and is qualified in its entirety by the terms and conditions of the Insider Trading Policy, a copy
of which is attached hereto as Exhibit 19.1 and is incorporated herein by reference.
Compensation Recovery and Clawback Policy
Under the Sarbanes-Oxley Act, in the event of
misconduct that results in a financial restatement that would have reduced a previously paid incentive amount, we can recoup those improper
payments from our executive officers. The SEC has also adopted the SEC Clawback Rule that directs national stock exchanges to require
listed companies to implement policies intended to recoup bonuses paid to executives if the company is found to have misstated its financial
results.
On July 2, 2025, our Board of Directors approved
the adoption of the Executive Compensation Clawback Policy (the Clawback Policy), in order to comply with the SEC Clawback
Rule, and the Nasdaq Rules, as set forth in Nasdaq Listing Rule 5608 (the Nasdaq Clawback Rules).
The Clawback Policy provides for the mandatory
recovery of erroneously awarded incentive-based compensation from our current and former executive officers as defined in the SEC Clawback
Rule (Covered Officers) in the event that we are required to prepare an accounting restatement, in accordance with the Nasdaq
Clawback Rules. The recovery of such compensation applies regardless of whether a Covered Officer engaged in misconduct or otherwise caused
or contributed to the requirement of an accounting restatement. Under the Clawback Policy, our Board of Directors may recoup from the
Covered Officers erroneously awarded incentive compensation received within a lookback period of the three completed fiscal years preceding
the date on which we are required to prepare an accounting restatement.
The foregoing description of the Clawback Policy
does not purport to be complete and is qualified in its entirety by the terms and conditions of the Clawback Policy, a copy of which
is attached hereto as Exhibit 97 and is incorporated herein by reference.
36
Item 11. Executive Officer and Director Compensation.
None of our executive officers or directors have
received any cash compensation for services rendered to us as of the date of this Report.
Our Audit Committee reviews on a quarterly basis
all payments that were made to our Sponsor, executive officers or directors, or our or their affiliates. Any such payments prior to an
initial Business Combination are made from funds held outside the Trust Account. Other than quarterly Audit Committee review of such reimbursements,
we do not have any additional controls in place governing our reimbursement or payments to our directors and executive officers for their
out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial
Business Combination.
We are not prohibited from paying any fees (including
advisory fees), reimbursements or cash payments to our Sponsor, officers or directors, or our or their affiliates, for services rendered
to us prior to or in connection with the completion of our initial Business Combination, including the following payments, all of which,
if made prior to the completion of our initial Business Combination, will be paid from funds held outside the Trust Account:
| 
| Reimbursement for office space, utilities, management, operations,
and secretarial and administrative support made available to us by an affiliate of our Sponsor, in an amount equal to $10,000 per month; | 
|
| 
| Our independent directors have received, for their services
as a director, an indirect interest in 23,000 Founder Shares through membership interests in our Sponsor, and our Chief Financial Officer
has received an indirect interest in 46,000 Founder Shares through membership interests in our Sponsor, and each of our independent directors
have acquired additional interests in the sponsor, for a total indirect ownership in the Company of 253,000 Founder Shares for each independent
director. None of such persons will have any right to control the sponsor or participate in any decision regarding the disposal of any
security held by the sponsor, or otherwise. Our Chief Executive Officer, through his ownership in the sponsor, has an indirect interest
in 3,063,600 Founder Shares, and our Special Advisor, through his ownership in the sponsor, has an indirect interest in 947,600 Founder
Shares. Our Chief Executive Officer, as the controlling member of Inflection Points, Inc. d/b/a Professional Capital Management, which
is the sole managing member of our Sponsor, has the right to control the Sponsor and participate in the decision regarding the disposal
of any security held by the Sponsor; | 
|
| 
| Payment of consulting, success or finder fees to our independent
directors, Special Advisor, or their respective affiliates in connection with the consummation of our initial Business Combination; | 
|
| 
| We may engage our Sponsor or an affiliate of our Sponsor
as an advisor or otherwise in connection with our initial Business Combination and certain other transactions and pay such person or
entity a salary or fee in an amount that constitutes a market standard for comparable transactions; | 
|
| 
| Reimbursement for any out-of-pocket expenses related to identifying,
investigating, negotiating and completing an initial Business Combination; and | 
|
| 
| Repayment of loans which may be made by our Sponsor or an
affiliate of our Sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial
Business Combination. Up to $1,500,000 of such loans may be convertible into private placement-equivalent Units of the post-Business
Combination entity at a price of $10.00 per Unit at the option of the applicable lender. Such Units would be identical to the Private
Placement Units. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist
with respect to such loans. | 
|
After the completion of our initial Business Combination,
directors or members of our Management Team who remain with us may be paid consulting or management fees from the combined company. All
of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials
furnished to our shareholders in connection with a proposed initial Business Combination. We have not established any limit on the amount
of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation
will be known at the time of the proposed initial Business Combination, because the directors of the post-combination business will be
responsible for determining executive officer and director compensation.
37
Any compensation to be paid to our executive officers
will be determined, or recommended to the Board of Directors for determination, either by a compensation committee constituted solely
by independent directors or by a majority of the independent directors on our Board of Directors.
We do not intend to take any action to ensure
that members of our Management Team maintain their positions with us after the consummation of our initial Business Combination, although
it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after
our initial Business Combination. The existence or terms of any such employment or consulting arrangements to retain their positions with
us may influence our Managements motivation in identifying or selecting a target business but we do not believe that the ability
of our Management to remain with us after the consummation of our initial Business Combination will be a determining factor in our decision
to proceed with any potential Business Combination. We are not party to any agreements with our officers and directors that provide for
benefits upon termination of employment.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The following table sets forth information regarding
the beneficial ownership of our Ordinary Shares as of March 12, 2026 based on information obtained from the persons named below, with
respect to the beneficial ownership of Ordinary Shares, by:
| 
| each person known by us to be the beneficial owner of more
than 5% of our outstanding Ordinary Shares; | 
|
| 
| each of our executive officers and directors that beneficially
owns our Ordinary Shares; and | 
|
| 
| all our executive officers and directors as a group. | 
|
In the table below, percentage ownership is based
on 31,680,000 shares of our Ordinary Shares, consisting of (i) 25,430,000 Class A ordinary shares and (ii) 6,250,000 Class B ordinary
shares, issued and outstanding as of March 12, 2026, including 25,000,000 Class A ordinary shares subject to possible redemption.
On all matters to be voted upon, except for (x) the appointment and removal of directors of the Board and (y) continuing our Company in
a jurisdiction outside the Cayman Islands, holders of the Class A ordinary shares and Class B ordinary shares vote together as a single
class, unless otherwise required by applicable law. Only holders of Class B ordinary shares have the right to vote on the appointment
and removal of directors prior to the completion of our initial Business Combination and on a vote to continue our Company in a jurisdiction
outside of the Cayman Islands. Currently, all of the Class B ordinary shares are convertible into Class A ordinary shares on a one-for-one
basis.
38
Unless otherwise indicated, we believe that all
persons named in the table have sole voting and investment power with respect to all Ordinary Shares beneficially owned by them. The following
table does not reflect record or beneficial ownership of the Private Placement Units as such Private Placement Units are not exercisable
within 60 days of the date of this Report.
| 
| | 
Class A ordinary shares | | | 
Class B ordinary shares | | | 
Approximate | | |
| 
Name and Address of Beneficial Owner(1) | | 
Number of Shares Beneficially Owned | | | 
Approximate Percentageof Outstanding Ordinary Shares | | | 
Number of Shares Beneficially Owned | | | 
Approximate Percentageof Outstanding Ordinary Shares | | | 
Percentageof Total Outstanding Ordinary Shares | | |
| 
ProCap Acquisition Sponsor, LLC(2)(3) | | 
| 430,000 | | | 
| 1.69 | % | | 
| 6,250,000 | | | 
| 100 | % | | 
| 21.09 | % | |
| 
Anthony Pompliano | | 
| 430,000 | | | 
| 1.69 | % | | 
| 6,250,000 | | | 
| 100 | % | | 
| 21.09 | % | |
| 
Catalina Abbey | | 
| | | | 
| | % | | 
| | | | 
| | % | | 
| | % | |
| 
Michael Gonzalez | | 
| | | | 
| | % | | 
| | | | 
| | % | | 
| | % | |
| 
Lindsey Haswell | | 
| | | | 
| | % | | 
| | | | 
| | % | | 
| | % | |
| 
Ben Buchanan | | 
| | | | 
| | % | | 
| | | | 
| | % | | 
| | % | |
| 
All officers and directors as a group (Fivepersons) | | 
| 430,000 | | | 
| 1.69 | % | | 
| 6,250,000 | | | 
| 100 | % | | 
| 21.09 | % | |
| 
Other 5% Shareholders | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
J. Goldman & Co LP(4) | | 
| 1,595,550 | | | 
| 6.27 | % | | 
| | | | 
| | % | | 
| 5.04 | % | |
| 
Meteora Capital, LLC(5) | | 
| 2,220,025 | | | 
| 8.73 | % | | 
| | | | 
| | % | | 
| 7.01 | % | |
| 
* | Less than one percent. | 
|
| 
(1) | Unless otherwise noted, the business address of each of the
following is c/o ProCap Acquisition Corp, 600 Lexington Ave, Floor 2, NewYork, NY10022. | 
|
| 
(2) | Interests shown consist of (i) Class A
ordinary shares, which represent the 430,000 Class A ordinary shares underlying the 430,000 Private Placement Units that Sponsor
purchased in the Private Placement, and (ii) Founder Shares, which are classified as ClassB ordinary shares. Such shares will
automatically convert into ClassA ordinary shares concurrently with or immediately following the consummation of our initial
Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment. | 
|
| 
(3) | ProCap Acquisition Sponsor, LLC, our Sponsor, is the record
holder of such shares. Mr.Pompliano, through his ownership of Inflection Points, Inc. d/b/a Professional Capital Management, which
is the sole managing member of ProCap Acquisition Sponsor, LLC and holds voting and investment discretion with respect to the ordinary
shares held of record by the sponsor. All of our officers and directors and our Special Advisor are members of our Sponsor. Each such
person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein,
directly or indirectly. Mr.Pompliano disclaims any beneficial ownership of the securities held by ProCap Acquisition Sponsor, LLC
other than to the extent of any pecuniary interest they may have therein, directly or indirectly. | 
|
| 
(4) | The reported position is according to a Schedule 13G filed with
the SEC November 14, 2025 by (i) J. Goldman & Co., L.P. (JGC) with respect the shares of the Company beneficially owned
by J. Goldman Master Fund, L.P. (JGMF) and J. Goldman Enhanced Master Fund, L.P. (JGEMF); (ii) J. Goldman
Capital Management, Inc. (JGCM) with respect to shares of the Company beneficially owned by JGMF and JGEMF; and (iii) Mr.
Jay G. Goldman with respect to shares of the Company beneficially owned by JGMF and JGEMF. The address of the principal place of business
office of JGC, JGCM and Mr. Goldman is c/o J. Goldman & Co., L.P., 510 Madison Avenue, 26th Floor, New York, NY 10022. | 
|
| 
(5) | The reported position is according to a Schedule 13G filed with
the SEC on February 6, 2026 by Meteora Capital, LLC, a Delaware limited liability company (Meteora Capital) with respect
to Class A ordinary shares held by certain funds and managed accounts to which Meteora Capital serves as investment manager (collectively,
the Meteora Funds). Mr. Vik Mittal serves as the Managing Member of Meteora Capital with respect to the Class A ordinary
shares held by the Meteora Funds. The principal business address of Meteora Capital is 1200 N Federal Hwy, #200, Boca Raton FL 33432. | 
|
Securities Authorized for Issuance under Equity
Compensation Plans
None.
Changes in Control
None.
39
Section 16(a) Beneficial Ownership Reporting Requirements
Section16(a)of the Securities ExchangeActof1934,
as amended, requires the Companys directors and executive officers, and persons who own more than 10% of a registered class of
the Companys equity securities, to file with the Securities and Exchange Commission initial reports of ownership and reports of
changes in ownership of equity securities of the Company. Officers, directors and greater than 10% stockholders are required to furnish
the Company with copies of all Section16(a)forms they file.
To the Companys knowledge, based solely
on review of forms filed in the SECs EDGAR database, all Section16(a)requirements applicable to persons who were officers,
directors and greater than 10% stockholders during the preceding fiscal year were complied with and satisfied on a timely basis, except
for a late Form 3 that was filed on May 22, 2025 for Michael Gonzalez, which disclosed that he had no beneficial ownership of equity securities
of the Company.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
On January9, 2025, our Sponsor purchased,
and the Company issued to the sponsor, 5,750,000 ClassB ordinary shares for paid $25,000, or approximately $0.004 per share, to
cover certain Initial Public Offering costs. On May 20, 2025, the Company effected a share recapitalization pursuant to which the Company
issued an additional 575,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate
6,325,000 founder shares issued and outstanding.
The number of Founder Shares outstanding was determined
based on the expectation that the total size of the Initial Public Offering would be a maximum of 23,000,000Units if the Underwriters
over-allotment option was exercised in full and excluding the ClassA ordinary shares underlying the Private Placement Units issued
to the sponsor, and therefore that such Founder Shares would represent 20% of the outstanding shares after the Initial Public Offering.
Up to 750,000 of the Founder Shares were to be surrendered for no consideration depending on the extent to which the Underwriters
over-allotment was exercised. On May 22, 2025, at the closing of the Companys Initial Public Offering, the Underwriters partially
exercised their over-allotment option. The remaining 75,000 Founder Shares were forfeited as of July 6, 2025, the expiration date of the
over-allotment option, as it remained unexercised.
Our independent directors received, for their
services as a director, an indirect interest in 23,000 Founder Shares through membership interests in our Sponsor, and our Chief Financial
Officer received an indirect interest in 46,000 Founder Shares through membership interests in our Sponsor, but none of such persons will
have any right to control the sponsor or participate in any decision regarding the disposal of any security held by the sponsor, or otherwise.
Additionally, our Chief Executive Officer, through his ownership in the sponsor, has an indirect interest in 3,063,600 Founder Shares,
and our Special Advisor, through his ownership in the sponsor, has an indirect interest in 947,600 Founder Shares. Our Chief Executive
Officer, as the controlling member of Inflection Points, Inc. d/b/a Professional Capital Management, which is the sole managing member
of our Sponsor, has the right to control the sponsor and participate in the decision regarding the disposal of any security held by the
sponsor.
Pursuant to the Private Placement Units Purchase
Agreement, our Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per unit for an aggregate purchase
price of $4,300,000. The Private Placement Units are identical to the Units sold in the Initial Public Offering except that, so long as
they are held by our Sponsor or its permitted transferees, the Private Placement Units (i)may not (including the ClassA ordinary
shares underlying these Private Placement Units), subject to certain limited exceptions, be transferred, assigned or sold by the holders
until 30days after the completion of our initial Business Combination, and (ii)will be entitled to registration rights.
Prior to or in connection with the completion
of our initial Business Combination, there may be payment by us to our Sponsor, officers or directors, Special Advisor, or our or their
affiliates, of a finders fee, advisory fee, consulting fee or success fee for any services they render in order to effectuate the
completion of our initial Business Combination, which, if made prior to the completion of our initial Business Combination, will be paid
from funds held outside the Trust Account.
Pursuant to the Administrative Services Agreement,
commencing on May 20, 2025, through the earlier of consummation of the initial Business Combination and our liquidation, we pay an affiliate
of the Sponsor an aggregate of $10,000 per month for office space, utilities, and secretarial and administrative support. For the period
from January 2, 2025 (inception) through December 31, 2025, we incurred and paid $70,000 in fees for these services pursuant to the
Administrative Services Agreement.
40
On January 9, 2025, the Sponsor agreed to loan
us an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to the IPO Promissory Note. This loan
was non-interest-bearing and payable on the earlier of December 31, 2025, or the date on which we consummated the Initial Public Offering.
We repaid all the outstanding balance of the IPO Promissory Note at the closing of the Initial Public Offering on May 22, 2025. As of
December 31, 2025, the IPO Promissory Note had been paid in full and borrowings under the IPO Promissory Note are no longer available.
In addition, in order to finance transaction costs
in connection with an intended initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and
directors may, but are not obligated to, loan us funds as may be required on a non-interest basis. If we complete an initial Business
Combination, we would repay such loaned amounts. In the event that the initial Business Combination does not close, we may use amounts
held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up
to $1,500,000 of such loans may be convertible into private placement-equivalent units of the post Business Combination entity at a price
of $10.00 per units at the option of the applicable lender. Such units would be identical to the Private Placement Units. Except as set
forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior
to the completion of our initial Business Combination, we do not expect to seek loans from parties other than our Sponsor or an affiliate
of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to
seek access to funds in our Trust Account.
Any of the foregoing payments to our Sponsor,
repayments of loans from our Sponsor or repayments of working capital loans prior to our initial Business Combination will be made using
funds held outside the Trust Account.
After our initial Business Combination, members
of our Management Team who remain with us may be paid consulting, management or other fees from the combined company with any and all
amounts being fully disclosed to our shareholders, to the extent then known, in the proxy solicitation or tender offer materials, as applicable,
furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender
offer materials or at the time of a general meeting held to consider our initial Business Combination, as applicable, as it will be up
to the directors of the post-combination business to determine executive and director compensation.
Pursuant to the Registration Rights Agreement,
the holders of the (i) Founder Shares, (ii) Private Placement Units and (iii) warrants that may be issued upon conversion of working capital
loans (and in each case holders of their underlying securities, as applicable) have registration rights to require us to register a sale
of any of our securities held by them and any other securities of our Company acquired by them prior to the consummation of our initial
Business Combination (in the case of the Founder Shares, only after conversion to our Class A Ordinary Shares). The holders of these securities
are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have
certain piggy-back registration rights with respect to registration statements filed subsequent to our completion of our
initial Business Combination. Notwithstanding anything to the contrary, BTIG may only make a demand on one occasion and only during the
five-year period beginning on the date the sales for the Initial Public Offering commenced.
Our Sponsor, directors and officers have also
entered into the Letter Agreement, with us, pursuant to which, they have waived their rights to liquidating distributions from the Trust
Account with respect to any Founder Shares held by them if we fail to complete our initial Business Combination within the Combination
Period. However, if our Sponsor, directors and officers acquire Public Shares in or after the Initial Public Offering, they will be entitled
to liquidating distributions from the Trust Account with respect to such Public Shares if we fail to complete our initial Business Combination
within the Combination Period.
Additionally, pursuant to the Letter Agreement,
our Sponsor, directors and officers will not propose any amendment to our Amended and Restated Memorandum (i) to modify the substance
or timing of our obligation to allow redemption in connection with our initial Business Combination or to redeem 100% of our Public Shares
if we do not complete our initial Business Combination within the Combination Period or (ii) with respect to any other material provisions
relating to shareholders rights or pre-initial Business Combination activity, in each case, unless we provide our Public Shareholders
with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously
released to us to pay our taxes, if any, divided by the number of then outstanding Public Shares. These restrictions do not apply to amendments
for the purposes of approving, or in conjunction with the consummation of, a Business Combination.
41
Director Independence
Nasdaq rules require that a majority of our Board
of Directors be independent within one year of our Initial Public Offering. An independent director is defined generally
as a person who, in the opinion of the companys board of directors, has no material relationship with the listed company (either
directly or as a partner, shareholder or officer of an organization that has a relationship with the company). Our Board has determined
that Mr.Buchanan, Mr.Gonzalez, and Ms. Haswell are independent directors as defined in Nasdaq listing standards
and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent directors are present.
Item 14*.* Principal Accountant Fees and
Services.
The firm of MaloneBailey, LLP (Malone),
acts as our independent registered public accounting firm. The following is a summary of fees paid to Malone for services rendered.
Audit Fees
Audit fees consist of fees for professional services
rendered for the audit of our year-end financial statements and services that are normally provided by Malone in connection with regulatory
filings. The aggregate fees of Malone for professional services rendered for the audit of our annual financial statements, review of
the financial information included in our Forms 10-Q for the respective periods and other required filings with the SEC for the period
from January 2, 2025 (inception) through December 31, 2025 totaled approximately $154,505. The above amounts include interim procedures
and audit fees, as well as attendance at Audit Committee meetings.
Audit-Related Fees
Audit-related fees consist of fees billed for
assurance and related services that are reasonably related to performance of the audit or review of our financial statements and are
not reported under Audit Fees. These services include attest services that are not required by statute or regulation and
consultations concerning financial accounting and reporting standards. We did not pay Malone for any audit-related fees for the period
from January 2, 2025 (inception) through December 31, 2025,
Tax Fees
Tax fees consist of fees billed for professional
services relating to tax compliance, tax planning and tax advice. We did not pay Malone for tax services, planning or advice for
the period from January 2, 2025 (inception) through December 31, 2025,
All Other Fees
All other fees consist of fees billed for all
other services. We did not pay Malone for any other services for the period from January 2, 2025 (inception) through December 31,
2025,
Pre-Approval Policy
Our Audit Committee was formed upon the consummation
of our Initial Public Offering. As a result, the Audit Committee did not pre-approve all of the foregoing services, although any services
rendered prior to the formation of our Audit Committee were approved by our Board of Directors. Since the formation of our Audit Committee,
and on a going-forward basis, the Audit Committee has and will pre-approve all auditing services and permitted non-audit services performed
and to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit
services described in the Exchange Act which are approved by the Audit Committee prior to the completion of the audit).
42
PART IV
Item 15. Exhibits, Financial Statement Schedules.
| 
(a) | The following documents are
filed as part of this Report: | 
|
| 
(1) | Financial Statements: | 
|
| 
| 
| 
Page | |
| 
Report
of Independent Registered Public Accounting Firm (PCAOB ID Number 206) | 
| 
F-2 | |
| 
Balance
Sheet as of December 31, 2025 | 
| 
F-3 | |
| 
Statement
of Operations fortheperiodfromJanuary2,2025 (Inception) through December 31, 2025 | 
| 
F-4 | |
| 
Statement
of Changes in Shareholders Deficit fortheperiodfromJanuary2,2025 (Inception) through December
31, 2025 | 
| 
F-5 | |
| 
Statement
of Cash Flows for the period from January 2, 2025 (Inception) through December 31, 2025 | 
| 
F-6 | |
| 
Notes
to Financial Statements | 
| 
F-7
to F-17 | |
| 
(2) | Financial Statement Schedules: | 
|
All financial statement schedules
are omitted because they are not applicable or the amounts are immaterial and not required, or the required information is presented in
the financial statements and notes thereto beginning on page F-1 of this Report.
| 
(3) | Exhibits | 
|
We hereby file as part of
this Report the exhibits listed in the attached Exhibit Index. Exhibits that are incorporated herein by reference can be inspected on
the SEC website at www.sec.gov.
Item
16. Form 10-K Summary.
Omitted at our Companys option.
43
PROCAP
ACQUISITION CORP
INDEX TO FINANCIAL STATEMENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID Number 206) | F-2 | |
| Financial Statements: | | |
| Balance Sheet as of December 31, 2025 | F-3 | |
| Statement of Operations fortheperiodfromJanuary2,2025 (Inception) through December 31, 2025 | F-4 | |
| Statement of Changes in Shareholders Deficit fortheperiodfromJanuary2,2025 (Inception) through December 31, 2025 | F-5 | |
| Statement of Cash Flows for the period from January 2, 2025 (Inception) through December 31, 2025 | F-6 | |
| Notes to Financial Statements | F-7 to F-17 | |
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
ProCap Acquisition Corp
*Opinion on the Financial Statements*
**
We have audited the accompanying balance sheet of ProCap Acquisition Corp ( the Company) as of December 31, 2025 and the related statements of operations, changes in shareholders deficit, and cash flows for the period from January 2, 2025 (inception) through December 31, 2025, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and the results of its operations and its cash flows for the period from January 2, 2025 (inception) through December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.
*Basis for Opinion*
**
These financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on the Companys financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
*/s/ MaloneBailey, LLP* 
www.malonebailey.com
We have served as the Companys auditor since 2025.
Houston, Texas 
March 16, 2026
F-2
PROCAP
ACQUISITION CORP 
BALANCE
SHEET
DECEMBER31,
2025
| 
Assets: | | 
| | |
| 
Current assets | | 
| | |
| Cash | | $ | 1,069,737 | | |
| Prepaid expenses | | | 124,358 | | |
| Total current assets | | | 1,194,095 | | |
| Cash held in Trust Account | | | 256,108,053 | | |
| Total Assets | | $ | 257,302,148 | | |
| 
| | 
| | | |
| 
Liabilities,
Class A Ordinary Shares Subject to Possible Redemption, and Shareholders Deficit | | 
| | | |
| 
Current liabilities | | 
| | | |
| Accrued offering costs | | $ | 75,000 | | |
| Accrued expenses | | | 17,444 | | |
| Promissory note related party | | | 23,345 | | |
| Total current liabilities | | | 115,789 | | |
| Deferred underwriting fee | | | 11,250,000 | | |
| Total Liabilities | | | 11,365,789 | | |
| 
| | 
| | | |
| Commitments and Contingencies (Note 6) | | | | | |
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,000,000 shares at redemption value of $10.24 per share | | | 256,108,053 | | |
| 
| | 
| | | |
| 
Shareholders
Deficit | | 
| | | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | | | | | |
| Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; 430,000 shares issued and outstanding (excluding 25,000,000 shares subject to possible redemption) | | | 43 | | |
| Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 6,250,000 shares issued and outstanding | | | 625 | | |
| Additional paid-in capital | | | | | |
| Accumulated deficit | | | (10,172,362 | ) | |
| Total Shareholders Deficit | | | (10,171,694 | ) | |
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders Deficit | | $ | 257,302,148 | | |
The
accompanying notes are an integral part of the financial statements.
F-3
PROCAP
ACQUISITION CORP 
STATEMENT
OF OPERATIONS
FOR
THE PERIOD FROM JANUARY 2, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025
| General and administrative costs | | $ | 470,085 | | |
| Loss from Operations | | | (470,085 | ) | |
| 
| | 
| | | |
| 
Other income: | | 
| | | |
| Change in fair value of over-allotment option liability | | | 21,211 | | |
| Interest earned on cash held in Trust Account | | | 6,108,053 | | |
| Total other income | | | 6,129,264 | | |
| 
| | 
| | | |
| Net income | | $ | 5,659,179 | | |
| 
| | 
| | | |
| Basic weighted average shares outstanding of Class A ordinary shares subject to possible redemption | | | 15,358,127 | | |
| Basic net income per ordinary share, Class A ordinary shares subject to possible redemption | | $ | 0.26 | | |
| Diluted weighted average shares outstanding of Class A ordinary shares subject to possible redemption | | | 15,358,127 | | |
| Diluted net income per ordinary share, Class A ordinary shares subject to possible redemption | | $ | 0.26 | | |
| Basic weighted average shares outstanding of Class A and Class B ordinary shares not subject to possible redemption | | | 6,118,843 | | |
| Basic net income per ordinary share, Class A and Class B ordinary shares not subject to possible redemption | | $ | 0.26 | | |
| Diluted weighted average shares outstanding of Class A and Class B ordinary shares not subject to possible redemption | | | 6,393,636 | | |
| Diluted net income per ordinary share, Class A and Class B ordinary shares not subject to possible redemption | | $ | 0.26 | | |
The
accompanying notes are an integral part of the financial statements.
F-4
PROCAP
ACQUISITION CORP
STATEMENT
OF CHANGES IN SHAREHOLDERS DEFICIT
FOR
THE PERIOD FROM JANUARY 2, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025
| 
| | 
Class
A Ordinary Shares | | | 
Class
B Ordinary Shares | | | 
Additional
Paid-in | | | 
Accumulated | | | 
Total
Shareholders | | |
| 
| | 
Shares | | | 
Amount | | | 
Shares | | | 
Amount | | | 
Capital | | | 
Deficit | | | 
Deficit | | |
| Balance January 2, 2025 (inception) | | | | | | $ | | | | | | | | $ | | | | $ | | | | $ | | | | $ | | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Class B ordinary shares issued to Sponsor (1) | | | | | | | | | | | 6,325,000 | | | | 633 | | | | 24,367 | | | | | | | | 25,000 | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Sale of Private Placement Units | | | 430,000 | | | | 43 | | | | | | | | | | | | 4,299,957 | | | | | | | | 4,300,000 | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Fair Value of Public Warrants at issuance | | | | | | | | | | | | | | | | | | | 1,816,667 | | | | | | | | 1,816,667 | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Allocated value of transaction costs to Private Placement Units, Public Warrants and Over-allotment option | | | | | | | | | | | | | | | | | | | (112,795 | ) | | | | | | | (112,795 | ) | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Forfeiture of Founder Shares | | | | | | | | | | | (75,000 | ) | | | (8 | ) | | | 8 | | | | | | | | | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Accretion for Class A ordinary shares to redemption value | | | | | | | | | | | | | | | | | | | (6,028,204 | ) | | | (15,831,541 | ) | | | (21,859,745 | ) | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Net income | | | | | | | | | | | | | | | | | | | | | | | 5,659,179 | | | | 5,659,179 | | |
| 
| | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | | 
| | | |
| Balance December 31, 2025 | | | 430,000 | | | $ | 43 | | | | 6,250,000 | | | $ | 625 | | | $ | | | | $ | (10,172,362 | ) | | $ | (10,171,694 | ) | |
| (1) | Included up to 75,000 Class B ordinary shares that were subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters. The remaining founder shares were forfeited on July 6, 2025, the expiration date of the over-allotment option, as the over-allotment option remained unexercised (see Note 5). | |
The
accompanying notes are an integral part of the financial statements.
F-5
PROCAP
ACQUISITION CORP
STATEMENT
OF CASH FLOWS
FOR
THE PERIOD FROM JANUARY 2, 2025 (INCEPTION) THROUGH DECEMBER 31, 2025
| 
Cash Flows
from Operating Activities: | | 
| | |
| Net income | | $ | 5,659,179 | | |
| 
Adjustments
to reconcile net income to net cash used in operating activities: | | 
| | | |
| Payment of general and administrative costs through promissory note related party | | | 80,895 | | |
| Interest earned on cash held in Trust Account | | | (6,108,053 | ) | |
| Change in fair value of over-allotment option liability | | | (21,211 | ) | |
| Adjustment to accrued offering costs | | | (35,000 | ) | |
| 
Changes
in operating assets and liabilities: | | 
| | | |
| Prepaid expenses | | | (79,358 | ) | |
| Accrued expenses | | | 17,444 | | |
| Net cash used in operating activities | | | (486,104 | ) | |
| 
| | 
| | | |
| 
Cash
Flows from Investing Activities: | | 
| | | |
| Investment of cash into Trust Account | | | (250,000,000 | ) | |
| Net cash used in investing activities | | | (250,000,000 | ) | |
| 
| | 
| | | |
| 
Cash
Flows from Financing Activities: | | 
| | | |
| Proceeds from sale of Units, net of underwriting discounts paid | | | 247,800,000 | | |
| Proceeds from sale of Private Placement Units | | | 4,300,000 | | |
| Repayment of promissory note related party | | | (200,659 | ) | |
| Payment of offering costs | | | (343,500 | ) | |
| Net cash provided by financing activities | | | 251,555,841 | | |
| 
| | 
| | | |
| Net Change in Cash | | | 1,069,737 | | |
| Cash Beginning of period | | | | | |
| Cash End of period | | $ | 1,069,737 | | |
| 
| | 
| | | |
| 
Noncash
investing and financing activities: | | 
| | | |
| Deferred offering costs included in accrued offering costs | | $ | 110,000 | | |
| Deferred offering costs paid through promissory note - related party | | $ | 123,109 | | |
| Prepaid expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | | $ | 25,000 | | |
| Prepaid services paid by Sponsor through the promissory note related party | | $ | 20,000 | | |
| Accretion of Class A ordinary shares to redemption value | | $ | 21,859,745 | | |
| Deferred underwriting fee payable | | $ | 11,250,000 | | |
| Forfeiture of Founder Shares | | $ | 8 | | |
The
accompanying notes are an integral part of the financial statements.
F-6
PROCAP
ACQUISITION CORP
NOTES
TO FINANCIAL STATEMENTS
DECEMBER
31, 2025
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
ProCap Acquisition Corp (the Company) is a blank check company incorporated as a Cayman Islands exempted corporation on January 2, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses (the Business Combination). The Company has not selected any specific Business Combination target and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target with respect to an initial Business Combination with the Company. 
As of December 31, 2025, the Company had not commenced any operations. All activity for the period from January 2, 2025 (inception) through December 31, 2025 relates to the Companys formation, the initial public offering (the Initial Public Offering), which is described below and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering which are held in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.
The registration statement for the Companys Initial Public Offering was declared effective on May 20, 2025. On May 22, 2025, the Company consummated the Initial Public Offering of 25,000,000 units (the Units and, with respect to the Class A ordinary shares included in the Units being offered, the Public Shares), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a Public Warrant). 
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 430,000 units (the Private Placement Units) at a price of $10.00 per Private Placement Unit, in a private placement to the Companys sponsor, ProCap Acquisition Sponsor, LLC (the Sponsor), generating gross proceeds of $4,300,000. Each Private Placement Unit consists of one Class A ordinary share and one-third of one redeemable warrant (the Private Placement Warrants and together with the Public Warrants, the Warrants). Each whole Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. 
Transaction costs amounted to $14,026,609, consisting of $2,200,000 of cash underwriting fee, $11,250,000 of deferred underwriting fee, and $576,609 of other offering costs. 
The Companys management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Placement Units, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination (less deferred underwriting commissions).
The Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held and income taxes payable on the income earned on the Trust Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the Investment Company Act). There is no assurance that the Company will be able to successfully effect a Business Combination. 
Following the closing of the Initial Public Offering, on May 22, 2025, an amount of $250,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and the Private Placement Units, was placed in the trust account (the Trust Account), with Odyssey Transfer and Trust Company acting as trustee. The funds are initially to be held in cash, including demand deposit accounts at a bank, or invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on management teams ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the sale of the Private Placement Units will not be released from the Trust Account until the earliest of (i) the completion of the Companys initial Business Combination, (ii) the redemption of the Companys public shares if the Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public Offering or by such earlier liquidation date as our board of directors may approve (the Completion Window), subject to applicable law, or (iii) the redemption of the Companys public shares properly submitted in connection with a shareholder vote to amend the Companys amended and restated memorandum and articles of association to (A) modify the substance or timing of the Companys obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Companys public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating to shareholders rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Companys creditors, if any, which could have priority over the claims of the Companys public shareholders. 
F-7
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
The Company will provide the Companys public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i)in connection with a general meeting called to approve the initial Business Combination or (ii)without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of twobusiness days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less income taxes payable), divided by the number of then outstanding public shares, subject to the limitations. The amount in the Trust Account is initially valued at $10.00 per public share. 
The ordinary shares subject to possible redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Boards (FASB) Accounting Standards Codification (ASC) Topic480 Distinguishing Liabilities from Equity.
The Company will have only the duration of the Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Completion Window, the Company will as promptly as reasonably possible but not more than tenbusiness days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less income taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will constitute full and complete payment for the public shares and completely extinguish public shareholders rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Companys obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law. 
The Sponsor, officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i)waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii)waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Companys amended and restated memorandum and articles of association; (iii)waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv)vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.
The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)$10.00 per public share and (ii)the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less income taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Companys indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Actof1933, as amended (the Securities Act). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsors only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. 
*Liquidity and Capital Resources*
On May 22, 2025, the Company consummated the Initial Public Offering of 25,000,000 Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit, in a private placement to the Sponsor, generating gross proceeds of $4,300,000. An amount of $1,523,391 was placed in an operating account to satisfy working capital requirements. As of December 31, 2025, the Company had cash of $1,069,737 and working capital of $1,078,306. 
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, members of the Companys founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (Working Capital Loans). If the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of December 31, 2025, the Company had no borrowings under the Working Capital Loans. 
In connection with the Companys assessment of going concern considerations in accordance with Accounting Standards Codification (ASC) 205-40, Presentation of Financial Statements - Going Concern, while there was substantial doubt previously, due to the cash on hand and working capital described above, the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. The Company has 24 months to complete the initial Business Combination from the date of the Initial Public Offering or until May 22, 2027. Management has determined that upon the receipt of the proceeds from the Initial Public Offering (see Note 3), the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statements.
F-8
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
**
*Basis of Presentation*
The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the SEC).
*Emerging Growth Company*
The Company is an emerging growth company, as defined in Section2(a)of the Securities Act, as modified by the Jumpstart our Business Startups Actof2012, (the JOBS Act), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section102(b)(1)of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the ExchangeAct) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Companys financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
*Use of Estimates*
The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses and other income during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
*Cash and Cash Equivalents*
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,069,737 in cash and no cash equivalents as of December 31, 2025. 
*Cash Held in Trust Account*
As of December 31, 2025, the assets held in the Trust Account, amounting to $256,108,053, were held in interest bearing demand deposit account. 
**
*Concentration of Credit Risk*
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Companys financial condition, results of operations, and cash flows. As of December 31, 2025, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. 
*Offering Costs*
The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (SAB) Topic 5A Expenses of Offering. Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, Debt with Conversion and Other Options, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and Warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders deficit as Public Warrants and Private Placement Warrants after managements evaluation were accounted for under equity treatment.
*Fair Value of Financial Instruments*
The fair value of the Companys assets and liabilities, which qualify as financial instruments under ASC Topic 820, Fair Value Measurement, approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
F-9
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
*Income Taxes*
The Company accounts for income taxes under ASC Topic740, Income Taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Companys management determined that the Cayman Islands is the Companys major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. 
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the UnitedStates. As such, the Companys tax provision was zero. 
*Net Income per Ordinary Share*
Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 75,000 ordinary shares that were forfeited on July 6, 2025 as the over-allotment option was not exercised by the underwriters (see Note 5). As of December 31, 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company for the periods presented. 
| | | FortheperiodfromJanuary2,2025 (Inception)throughDecember31,2025 | | |
| | | Class A redeemable | | | Class A and Class B non-redeemable | | |
| Basic net income per ordinary share | | | | | | | |
| Numerator: | | | | | | | |
| Allocation of net income | | $ | 4,046,865 | | | $ | 1,612,314 | | |
| Denominator: | | | | | | | | | |
| Basic weighted average ordinary shares outstanding | | | 15,358,127 | | | | 6,118,843 | | |
| Basic net income per ordinary share | | $ | 0.26 | | | $ | 0.26 | | |
| | | FortheperiodfromJanuary2,2025 (Inception)throughDecember31,2025 | | |
| | | Class A redeemable | | | Class A and Class B non-redeemable | | |
| Diluted net income per ordinary share | | | | | | | |
| Numerator: | | | | | | | |
| Allocation of net income | | $ | 3,995,740 | | | $ | 1,663,439 | | |
| Denominator: | | | | | | | | | |
| Diluted weighted average ordinary shares outstanding | | | 15,358,127 | | | | 6,393,636 | | |
| Diluted net income per ordinary share | | $ | 0.26 | | | $ | 0.26 | | |
*Derivative Financial Instruments*
The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic815, Derivatives and Hedging. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net cash settlement or conversion of the instrument could be required within 12months of the balance sheet date. The underwriters over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480 if not fully exercised at the time of the Initial Public Offering. On May 22, 2025, at the closing of the Companys Initial Public Offering, the underwriters partially exercised their over-allotment option. There was no remaining over-allotment liability as of December 31, 2025 as the remaining portion of the over-allotment option expired unexercised on July 6, 2025 (see Note 5). 
F-10
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
**
*Warrant Instruments*
The Company accounted for the Public Warrants issued in connection with the Initial Public Offering and the Private Placement Warrants issued as part of the Private Placement Units, in accordance with the guidance contained in FASB ASC Topic815, Derivatives and Hedging. Accordingly, the Company evaluated and classified the Warrant instruments under equity treatment at their assigned values.
Class A Ordinary Shares Subject to Possible Redemption
The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Companys liquidation, or if there is a shareholder vote or tender offer in connection with the Companys initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders deficit section of the Companys balance sheet. As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table: 
| Gross proceeds | | $ | 250,000,000 | | |
| Less: | | | | | |
| Proceeds allocated to Public Warrants | | | (1,816,667 | ) | |
| Proceeds allocated to over-allotment option | | | (21,211 | ) | |
| Class A ordinary shares issuance costs | | | (13,913,814 | ) | |
| Plus: | | | | | |
| Initial measurement of carrying value to redemption value | | | 15,751,692 | | |
| Remeasurement of carrying value to redemption value | | | 6,108,053 | | |
| Class A Ordinary Shares subject to possible redemption, December 31, 2025 | | $ | 256,108,053 | | |
**
*Recent Accounting Pronouncements*
Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Companys financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering on May 22, 2025, the Company sold 25,000,000Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 3,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one ClassA ordinary share, and one-third of one redeemable Public Warrant. 
Each Warrant will become exercisable 30 days after the completion of the Companys initial Business Combination and will expire five years after the completion of the Companys initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination within the Completion Window, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of common stock to the holder upon exercise of the Warrants during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the warrants become exercisable, the Company may redeem the outstanding warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days prior written notice of redemption, only in the event that the last sale price of the Companys shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period commencing at any time after the shares underlying the warrants have become exercisable and ending on the third trading day before the Company sends the notice of redemption to the warrant holders. 
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per unit, or $4,300,000 in the aggregate, in a private placement. 
The Private Placement Unitsare identical to the Public Unitssold in the Initial Public Offering except that, so long as they are held by the Sponsor, the underwriters or their permitted transferees, the Private Placement Units(i)may not (including the ClassA ordinary shares issuable upon exercise of these Private Placement Units), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30days after the completion of the initial Business Combination and (ii)will be entitled to registration rights. 
F-11
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
The Sponsor and the Companys officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i)waive their redemption rights with respect to their founder shares and public shares in connection with the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination; (ii)waive their redemption rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Companys amended and restated memorandum and articles of association (A)to modify the substance or timing of the Companys obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B)with respect to any other material provisions relating to shareholders rights or pre-initial Business Combination activity; (iii)waive their rights to liquidating distributions from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from assets outside the Trust Account; and (iv)vote any founder shares held by them and any public shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions) in favor of the initial Business Combination. 
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On January9, 2025, the Sponsor purchased, and the Company issued to the Sponsor, 5,750,000 ClassB ordinary shares (founder shares) for $25,000, or approximately $0.004 per share. On May 20, 2025, the Company effected a share recapitalization pursuant to which the Company issued an additional 575,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 6,325,000 founder shares issued and outstanding. All share and per share data has been retroactively presented. Up to 825,000 of the founder shares may be surrendered by the Sponsor for no consideration depending on the extent to which the underwriters over-allotment option is exercised. On May 22, 2025, the underwriters partially exercised their over-allotment option, and as a result, 750,000 founder shares are no longer subject to forfeiture and up to 75,000 of the founder shares may be surrendered by the Sponsor for no consideration depending on the extent to which the remainder of the underwriters over-allotment option is not exercised. The remaining 75,000 founder shares were forfeited as of July 6, 2025, the expiration date of the over-allotment option, as it remained unexercised. 
The Companys initial shareholders have agreed not to transfer, assign or sell any of their founder shares and any ClassA ordinary shares issued upon conversion thereof until the earlier to occur of (i)sixmonths after the completion of the initial Business Combination or (ii)the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Companys shareholders having the right to exchange their ClassA ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Companys initial shareholders with respect to any founder shares (the Lock-up). Notwithstanding the foregoing, if (1)the closing price of the ClassA ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20trading days within any 30-tradingday period commencing after the initial Business Combination or (2)if the Company consummates a transaction after the initial Business Combination which results in the Companys shareholders having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the Lock-up. 
Promissory NoteRelated Party
The Sponsor has agreed to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing, unsecured and due at the earlier of December31, 2025, or the closing of the Initial Public Offering. As of December 31, 2025, the Company had an outstanding borrowing of $23,345 under the promissory note, which is now due on demand. Borrowings under the note are no longer available. 
Administrative Services Agreement
The Company entered into an agreement with an affiliate of the Sponsor, commencing on May 20, 2025 through the earlier of the Companys consummation of initial Business Combination and its liquidation, to pay the affiliate of the Sponsor an aggregate of $10,000 per month for office space, utilities, management, operations, and secretarial and administrative support services. For the period from January2, 2025 (inception) through December 31, 2025, the Company incurred and paid $70,000 in fees for these services. 
Working Capital Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Companys officers and directors may, but are not obligated to, loan the Company funds as may be required (the Working Capital Loans). If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at a price of $10.00 per unit at the option of the lender. The units would be identical to the Private Placement Units. As of December 31, 2025, no such Working Capital Loans were outstanding. 
F-12
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
NOTE 6. COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
The UnitedStates and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the recent escalation of the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (NATO) deployed additional military forces to eastern Europe, and the UnitedStates, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the UnitedStates, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the UnitedStates, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyberattacks against U.S.companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Companys search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.
Registration Rights
The holders of the founder shares, Private Placement Warrants and the ClassA ordinary shares underlying such Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans will have registration rights to require the Company to register for resale of any of the Companys securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain piggy-back registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
**
Underwriting Agreement
The underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,300,000units to cover over-allotments, if any. On May 22, 2025, the underwriters partially exercised the over-allotment option to purchase an additional 3,000,000 Units. The underwriters had 45 days from the date of the Initial Public Offering to purchase the remaining 300,000 Units. The remaining over-allotment option expired on July 6, 2025, as it remained unexercised (see Note 5). 
The underwriters were entitled to a cash underwriting discount of $2,200,000 (regardless of whether the underwriters over-allotmentoption is exercised in full), which was paid at the closing of the Initial Public Offering. Additionally, the underwriters were entitled to a deferred underwriting discount of $11,250,000 (4.50% of the gross proceeds of the Initial Public Offering held in the Trust Account), payable upon the completion of the Companys initial Business Combination subject to the terms of the underwriting agreement, but $0.10 per unit of such $0.45 per unit shall be due solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions in connection with the consummation of the initial Business Combination and $0.05 per unit of such $0.45 per unit shall be allocable by the Company. 
F-13
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
NOTE 7. SHAREHOLDERS DEFICIT
*Preference Shares*The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. As of December 31, 2025, there were no preference shares issued or outstanding. 
**
*ClassA Ordinary Shares*The Company is authorized to issue a total of 300,000,000 ClassA ordinary shares at par value of $0.0001 each. As of December 31, 2025, there were 430,000 Class A ordinary shares issued and outstanding, excluding 25,000,000 shares subject to possible redemption. 
*ClassB Ordinary Shares*The Company is authorized to issue a total of 30,000,000 ClassB ordinary shares at par value of $0.0001 each. As of December 31, 2025, there were 6,250,000 Class B ordinary shares issued and outstanding. 
The founder shares will automatically convert into ClassA ordinary shares concurrently with or immediately following the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional ClassA ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with the closing of the initial Business Combination, the ratio at which ClassB ordinary shares convert into ClassA ordinary shares will be adjusted (unless the holders of a majority of the outstanding ClassB ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of ClassA ordinary shares issuable upon conversion of all ClassB ordinary shares will equal, in the aggregate, 20% of the sum of (i)the total number of all ClassA ordinary shares outstanding upon the completion of this offering (including any ClassA ordinary shares issued pursuant to the underwriters over-allotment option and excluding the ClassA ordinary shares underlying the private placement warrants issued to the Sponsor), plus (ii)all ClassA ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to our Sponsor or any of its affiliates or to our officers or directors upon conversion of working capital loans) minus (iii)any redemptions of ClassA ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis. 
Holders of record of the Companys ClassA ordinary shares and ClassB ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by our shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting, and pursuant to the amended and restated memorandum and articles of association, such actions include amending our amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following our initial Business Combination, the holders of more than 50% of the ordinary shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the ClassB ordinary shares will (i)have the right to vote on the appointment and removal of directors and (ii)be entitled to vote on continuing our company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of our approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the ClassA ordinary shares will not be entitled to vote on these matters during such time. These provisions of the amended and restated memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. 
F-14
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
WarrantsAs of December 31, 2025, there were 8,476,666 Warrants outstanding, including 8,333,333 Public Warrants and 143,333 Private Placement Warrants. Each whole Public Warrant entitles the holder to purchase one ClassA ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. The Warrants cannot be exercised until 30days after the completion of the initial Business Combination, and will expire at 5:00p.m., NewYork City time, fiveyears after the completion of the initial Business Combination or earlier upon redemption or liquidation. 
The Company will not be obligated to deliver any ClassA ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ClassA ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a ClassA ordinary share upon exercise of a warrant unless the ClassA ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the ClassA ordinary share underlying such unit.
Under the terms of the warrant agreement, the Company has agreed that, as soon as practicable, but in no event later than 20business days, after the closing of its Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the Initial Public Offering or a new registration statement covering the registration under the Securities Actofthe ClassA ordinary shares issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60business days following the Companys initial Business Combination and to maintain a current prospectus relating to the ClassA ordinary shares issuable upon exercise of the warrants until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the ClassA ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) businessday after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a cashless basis in accordance with Section3(a)(9)of the Securities Act or another exemption. Notwithstanding the above, if the ClassA ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a covered security under Section18(b)(1)of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a cashless basis in accordance with Section3(a)(9)of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. 
If the holders exercise their public warrants on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of ClassA ordinary shares equal to the quotient obtained by dividing (x)the product of the number of ClassA ordinary shares underlying the warrants, multiplied by the excess of the fair market value of the ClassA ordinary shares over the exercise price of the warrants by (y)the fair market value. The fair market value is the average reported closing price of the ClassA ordinary shares for the 10trading days ending on the thirdtrading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable. 
*Redemption of Warrants When the Price per ClassA Ordinary Share Equals or Exceeds $18.00*: The Company may redeem the outstanding warrants: 
| | in whole and not in part; | |
| | at a price of $0.01 per warrant; | |
| | upon a minimum of 30days prior written notice of redemption (the 30-day redemption period); and | |
| | if, and only if, the closing price of the ClassA ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20trading days within a 30-tradingday period commencing at least 30days after completion of our initial Business Combination and ending threebusiness days before we send the notice of redemption to the warrant holders. | |
F-15
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
Additionally, if the number of outstanding ClassA ordinary shares is increased by a share capitalization payable in ClassA ordinary shares, or by a sub-division of ordinary shares or other similar event, then, on the effective date of such share capitalization, sub-division or similar event, the number of ClassA ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase ClassA ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number of ClassA ordinary shares equal to the product of (i)the number of ClassA ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for ClassA ordinary shares) and (ii)the quotient of (x)the price per ClassA ordinary share paid in such rights offering and (y)the fair market value. For these purposes (i)if the rights offering is for securities convertible into or exercisable for ClassA ordinary shares, in determining the price payable for ClassA ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii)fair market value means the volume weighted average price of ClassA ordinary shares as reported during the ten (10)trading day period ending on thetrading day prior to the first date on which the ClassA ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. 
NOTE 8. FAIR VALUE MEASUREMENTS 
The fair value of the Companys financial assets and liabilities reflects managements estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
| | Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
| | | | |
| | Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
| | | | |
| | Level 3: | Unobservable inputs based on assessment of the assumptions that market participants would use in pricing the asset or liability. | |
The following table presents information about the Companys assets, liabilities, and equity, that are measured at fair value as of December 31, 2025, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
| | | Level | | | December 31, 2025 | | |
| Assets: | | | | | | | |
| Cash held in Trust Account | | | 1 | | | $ | 256,108,053 | | |
| Equity: | | | | | | | | | |
| Fair value of Public Warrants for ordinary shares subject to possible redemption allocation | | | 3 | | | $ | 1,816,667 | | |
The Company used a Black-Scholes model to value the over-allotment option. The over-allotment option liability was classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs inherent in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the option. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the option. The expected life of the option is assumed to be equivalent to their remaining contractual term.
The key inputs into the Black-Scholes model were as follows for the over-allotment option:
| Inputs | | May 22, 2025 (initial measurement) | | |
| Risk-free interest rate | | | 4.37 | % | |
| Expected term (years) | | | 0.12 | | |
| Expected volatility | | | 2.75 | % | |
| Exercise price | | $ | 10.00 | | |
| Fair value of over-allotment unit | | $ | 0.071 | | |
The fair value of the initial over-allotment option liability was $21,211. During the period from January 2, 2025 (inception) through December 31, 2025, the company recognized other income of $21,211 attributable to the change in the fair value of the over-allotment option liability. As of December 31, 2025 there was no longer an over-allotment liability included in the Companys balance sheet as the over-allotment option liability expired unexercised on July 6, 2025, the expiration date. 
F-16
PROCAP ACQUISITION CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025
The fair value of the Public Warrants is $1,816,667, or $0.218 per Public Warrant. The fair value of Public Warrants was determined using Monte Carlo Simulation Model. The Public Warrants have been classified within shareholders deficit and will not require remeasurement after issuance. The Public Warrants was classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs inherent in pricing models are assumptions related to volatility, remaining term in years, risk free rate, pre-adjusted value per share and implied market adjustment. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants: 
| | | May 22, 2025 | | |
| Underlying stock price | | $ | 10.72 | | |
| Exercise price | | $ | 11.50 | | |
| Volatility | | | 5.3 | % | |
| Remaining term (years) | | | 7.01 | | |
| Risk-free rate | | | 4.23 | % | |
| Pre-adjusted value per share | | $ | 2.18 | | |
| Implied market adjustment | | | 10.0 | % | |
NOTE 9. SEGMENT INFORMATION
ASC Topic280, Segment Reporting, establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Companys chief operating decision maker, or group, in deciding how to allocate resources and assess performance.
The Companys chief operating decision maker has been identified as the Chief Executive Officer (CODM), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment. 
The key measures of segment profit or loss reviewed by the CODM are interest on the Cash Held in Trust Account and general and administrative expenses. The CODM reviews interest earned on the Cash Held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the Business Combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.
The segment measures of profitability are shown in the statements of operations. The measure of segment assets is reported on the balance sheet as total assets.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
F-17
EXHIBIT INDEX
Exhibit Index
| 
ExhibitNo. | 
| 
Description | |
| 
3.1* | 
| 
Amended and Restated Memorandum and Articles of Association, incorporated by reference to Exhibit 3.1 of the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
4.1* | 
| 
Specimen Unit Certificate, incorporated by reference to Exhibit 4.1 of the Companys Form S-1, as filed with the SEC on April 30, 2025. | |
| 
4.2* | 
| 
Specimen Ordinary Share Certificate, incorporated by reference to Exhibit 4.2 the Companys Form S-1, as filed with the SEC on April 30, 2025. | |
| 
4.3* | 
| 
Specimen Warrant Certificate (included as an exhibit to Exhibit 4.4). | |
| 
4.4* | 
| 
Warrant Agreement, dated May 20, 2025, between Odyssey Transfer and Trust Company and the Registrant, incorporated by reference to Exhibit 4.4 of the Companys Form S-1, as filed with the SEC on April 30, 2025. | |
| 
4.5** | 
| 
Description of Securities. | |
| 
10.1* | 
| 
Letter Agreement, dated May 20, 2025, between the Registrant, ProCap Acquisition Sponsor, LLC and each of the officer and directors of the Registrant, incorporated by reference to Exhibit 10.1 of the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
10.2* | 
| 
Investment Management Trust Agreement, dated May 20, 2025, between Odyssey Transfer and Trust Company and the Registrant, incorporated by reference to Exhibit 10.2 of the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
10.3* | 
| 
Form of Registration Rights Agreement, dated May 20, 2025, among the Registrant and ProCap Acquisition Sponsor, LLC, incorporated by reference to Exhibit 10.3 of the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
10.4* | 
| 
Private Placement Unit Purchase Agreement, dated May 20, 2025, between the Registrant and ProCap Acquisition Sponsor, LLC, incorporated by reference to the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
10.5* | 
| 
Form of Indemnity Agreement, as incorporated by reference to the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
10.6* | 
| 
Promissory Note dated January 9, 2025, issued to ProCap Acquisition Sponsor, LLC and the Registrant, incorporated by reference to Exhibit 10.6 of the Companys Form S-1, as filed with the SEC on April 30, 2025. | |
| 
10.7* | 
| 
Securities Subscription Agreement dated January 9, 2025, between ProCap Acquisition Sponsor, LLC and the Registrant, incorporated by reference to Exhibit 10.7 of the Companys Form S-1, as filed with the SEC on April 30, 2025. | |
| 
10.8* | 
| 
Administrative Services Agreement, dated May 20,2025, between the Registrant and an affiliate of the Registrant, incorporated by reference to Exhibit 10.6 of the Companys Form 8-K, as filed with the SEC on May 27, 2025. | |
| 
14.1* | 
| 
Form of Code of Ethics. | |
| 
19.1** | 
| 
Insider Trading Policy | |
| 
21.1** | 
| 
List of Subsidiaries. | |
| 
31.1** | 
| 
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 
31.2** | 
| 
Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
| 
32.1** | 
| 
Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 
32.2** | 
| 
Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
| 
97* | 
| 
Clawback Policy, as incorporated by reference to Exhibit 99.1 of the Companys Form 10-Q, as filed with the SEC on July 3, 2025. | |
| 
99.1* | 
| 
Audit Committee Charter. | |
| 
99.2* | 
| 
Compensation Committee Charter. | |
| 
101.NS | 
| 
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because the XBRL tags are embedded within the Inline XBRL document. | |
| 
101.SCH | 
| 
Inline XBRL Taxonomy Extension Schema Document | |
| 
101.CAL | 
| 
Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
| 
101.DEL | 
| 
Inline XBRL Taxonomy Extension Definition Linkbase Document | |
| 
101.DRF | 
| 
Inline XBRL Taxonomy Extension Label Linkbase Document | |
| 
101.PRE | 
| 
Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 
104 | 
| 
Cover Page Interaction Data File (formatted as inline XBRL with application taxonomy extension information contained in Exhibit 101). | |
| 
* | Previously filed | 
|
| 
** | Filed herewith | 
|
44
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| 
March 16, 2026 | 
ProCap Acquisition Corp | |
| 
| 
| 
| |
| 
| 
By: | 
/s/ Anthony J. Pompliano | |
| 
| 
Name: | 
Anthony J. Pompliano | |
| 
| 
Title: | 
Chief Executive Officer and Director | |
Pursuant to the requirements
of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in
the capacities and on the dates indicated.
| 
Name | 
| 
Position | 
| 
Date | |
| 
| 
| 
| |
| 
/s/ Anthony J. Pompliano | 
| 
Chief Executive Officer and Director | 
| 
March 16, 2026 | |
| 
Anthony J. Pompliano | 
| 
(Principal Executive Officer) | 
| 
| |
| 
| 
| 
| |
| 
/s/ Catalina Abbey | 
| 
Chief Financial Officer | 
| 
March 16, 2026 | |
| 
Catalina Abbey | 
| 
(Principal Financial and Accounting Officer) | 
| 
| |
| 
| 
| 
| |
| 
/s/ Michael Gonzalez | 
| 
Independent Director | 
| 
March 16, 2026 | |
| 
Michael Gonzalez | 
| 
| 
| 
| |
| 
| 
| 
| |
| 
/s/ Lindsey Haswell | 
| 
Independent Director | 
| 
March 16, 2026 | |
| 
Lindsey Haswell | 
| 
| 
| 
| |
| 
| 
| 
| 
| 
| |
| 
/s/ Ben Buchanan | 
| 
Independent Director | 
| 
March 16, 2026 | |
| 
Ben Buchanan | 
| 
| 
| 
| |
45